Introduction {#s1}
============

Ca^2+^ ions crossing the neuronal plasma membrane are critically involved in depolarization and distribute in the cytosol in spatial microdomains and organelles to regulate a wide range of processes ranging from gene expression to fast transmitter release ([@bib14]; [@bib67]). In axons, voltage-gated Ca^2+^ (Ca~V~) channels at presynaptic terminals open in response to a single action potential (AP), raising intracellular Ca^2+^ concentrations (\[Ca^2+^\]~i~) in nanodomains from \~50 nM up to \~10 µM to increase transmitter vesicle release rates by the power of \~4 ([@bib42]; [@bib79]). In response to APs, large and local \[Ca^2+^\]~i~ transients are typically also observed in the axon initial segment (AIS) and nodes of Ranvier ([@bib19]; [@bib11]; [@bib90]; [@bib35]; [@bib93]; [@bib24]). At these sites, Ca^2+^ currents have been implicated in AP initiation and propagation by a local depolarizing action of the inward current or by activating the large conductance, Ca^2+^- and voltage-dependent K^+^ (BK~Ca~) channels modulating burst firing probability and limiting frequency-dependent AP failure rates ([@bib11]; [@bib90]; [@bib46]). The Ca~V~ channel subtypes identified in axons are both cell type- and species-dependent and include the T-, P/Q- or N-type Ca~V~ channels ([@bib19]; [@bib11]; [@bib90]; [@bib35]; [@bib93]). At the AIS in particular the T-type Ca^2+^ channel mediates AP-dependent Ca^2+^ influx ([@bib11]; [@bib62]; [@bib32]; [@bib52]). However, in the prefrontal cortical pyramidal neuron AIS about 70% of the AP-evoked \[Ca^2+^\]~i~ remains following pharmacological block of T-type Ca~V~ channels ([@bib24]). Furthermore, evidence for a clustering of T-type Ca~V~ channels at the AIS is ambiguous and immunofluorescence or immuno-gold labeling studies show a density which is comparable to somatodendritic or spine compartments ([@bib63]; [@bib62]).

Several other mechanisms may contribute to axoplasmic \[Ca^2+^\]~i~ elevations in the AIS. Firstly, Ca^2+^ levels could rise due to Ca^2+^-induced Ca^2+^ release from intracellular sources such as the endoplasmic reticulum (ER). Most AISs contain ER cisternae organelles consisting of stacks of membranes expressing the store-operated ryanodine receptor (RyR), inositol 1,4,5-triphosphate receptor 1(IP~3~R1) and sarcoplasmic ER Ca^2+^ ATPase (SERCA) pumps ([@bib12]; [@bib53]; [@bib4]). The coupling of transmembrane Ca^2+^ entry with intracellular store release may generate a local activity-dependent rise of \[Ca^2+^\]~i~. However, a contribution of ER stores to AIS \[Ca^2+^\]~i~ remains to be directly demonstrated. Secondly, near the peak of the AP the electrogenic Na^+^-Ca^2+^ exchanger (NCX) reverses direction and imports Ca^2+^. A reverse mode of operation has not only been implicated in pathological \[Ca^2+^\]~i~ elevations in axons during hypoxia and injury ([@bib80]; [@bib49]), but also occurs during trains of APs in nodes and neighboring internodes ([@bib93]). Finally, one alternative pathway that has yet to be directly examined in mammalian cortical axons involves the voltage-gated Na^+^ (Na~V~) channels. Studies in the squid giant axon combining electrophysiological recordings with Ca^2+^ imaging showed that an early component of depolarization-induced Ca^2+^ entry is tetrodotoxin (TTX)-sensitive ([@bib6]; [@bib64]; [@bib18]). Voltage-clamp recordings from axons and perfusing distinct ionic solutions provided a quantitative estimate that Na~V~ channels may pass divalent Ca^2+^ ions with permeability ratios (*P*~Ca~/*P*~Na~) up to 0.10 ([@bib44]; [@bib64]). Ca^2+^ permeability of Na~V~ channels has also been shown in cardiac cells and hippocampal neurons ([@bib3]; [@bib1]; [@bib75]) but whether this extends to the cortical axons remains to be examined.

Here, using wide-field Ca^2+^ imaging with a high-speed CCD camera enabling detection of \[Ca^2+^\]~i~ changes at high sensitivity and high temporal resolution ([@bib50]; [@bib2]), we explored the various pathways of Ca^2+^ entry in axons of rat thick-tufted neocortical layer 5 (L5) pyramidal neurons. We found that during subthreshold depolarizations \[Ca^2+^\]~i~ transients were highly compartmentalized to the AIS and nodes of Ranvier. While these transients were amplified by ER store release, the trigger was only modestly accounted for by Ca~V~ channels. The largest fraction of activity-dependent \[Ca^2+^\]~i~ was TTX-sensitive and overlapped with the rapid gating of Na~V~ channels. Experiments in HEK-293 cells transfected with the human Na~V~1.2 channel confirmed that TTX-sensitive Na^+^ currents were sufficient to generate \[Ca^2+^\]~i~ elevations. Together, the data suggest that \[Ca^2+^\]~i~ dynamics in the mammalian AIS are predominantly mediated by a rapid Ca^2+^ entry through Na~V~ channels.

Results {#s2}
=======

Activity-dependent compartmentalized Ca^2+^ entry in layer five axons {#s2-1}
---------------------------------------------------------------------

Thick-tufted L5 pyramidal neurons, also called L5B or pyramidal tract neurons, are the largest pyramidal neurons in the cortex and integrate synaptic inputs from all cortical layers, playing a central role in cognitive tasks including perception ([@bib34]; [@bib71]; [@bib83]). Their large axons (\~1.5 µm in diameter) send long-range output projections to the thalamus, striatum and spinal cord, but within the cortex branch sparsely and have a trajectory perpendicular to the pia providing an excellent anatomical arrangement to image and record from. To optically record the spatial profile of axonal \[Ca^2+^\]~i~ we made somatic whole-cell patch-clamp recordings from neurons filled with the high-affinity Ca^2+^ indicator Oregon Green BAPTA 1 (OGB-1, 100 µM) and imaged epifluorescence signals along the proximal region of the main axon ([Figure 1](#fig1){ref-type="fig"}). We first used subthreshold depolarizations evoked by artificial excitatory postsynaptic potentials (a-EPSPs, 100 Hz, peak depolarization 17.0 ± 0.6 mV, *n* = 15; [Figure 1a](#fig1){ref-type="fig"}). Examination of the spatial profile revealed that Ca^2+^ signals were observed in the AIS and hot spots separated with regular distances along the axon (locations 2, 4 and 6; [Figure 1a](#fig1){ref-type="fig"}). In order to examine whether the \[Ca^2+^\]~i~ hot spots corresponded to nodes of Ranvier, we post-hoc stained for βIV-spectrin and biocytin, and found indeed overlap between subthreshold \[Ca^2+^\]~i~ rise and spectrin-enriched sites ([Figure 1b](#fig1){ref-type="fig"}). In the same cells we examined the spatial profile of Δ\[Ca^2+^\]~i~ in response to a single AP evoked with a brief square current injection ([Figure 1c](#fig1){ref-type="fig"}). As expected from back- and forward-propagating APs with much higher depolarizations (\~100 mV), large \[Ca^2+^\]~i~ transients were observed widespread throughout all axonal and somatodendritic domains. Population analysis showed that AP-induced \[Ca^2+^\]~i~ transients were similar between AIS and nodes (one-way ANOVA followed by Tukey's multiple comparison test, p\<0.0001, differences between all groups were significant (p*\<*0.05) except between AIS and node (p*=*0.13) and between internode (IN) and dendrites (p*=*0.85); [Figure 1c,d](#fig1){ref-type="fig"}). Interestingly, also during a-EPSPs the \[Ca^2+^\]~i~ transients in the AIS and the first nodes were highly comparable, while \[Ca^2+^\]~i~ signals in the internodal and dendritic domains were an order of magnitude smaller (one-way ANOVA with Tukey's multiple comparison test, p\<0.0001, differences between all groups were significant (p\<0.0001), except between AIS and node (p*=*0.38) and IN and Dend (p*=*0.97); [Figure 1a,d](#fig1){ref-type="fig"}). Similar experiments in L5 neocortical pyramidal neurons in slices from human temporal cortex also revealed a-EPSP evoked Δ\[Ca^2+^\]~i~ in the AIS, but not in the dendrite, suggesting that subthreshold sensitive \[Ca^2+^\]~i~ transients are conserved across mammalian species ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Together, these results show that activity-dependent \[Ca^2+^\]~i~ transients are spatiotemporally compartmentalized and Ca^2+^ entry dynamics are similar in the axoplasm of the AIS and nodes.

![Activity-dependent compartmentalized Ca^2+^ entry in layer five axons.\
(**a**) *Left*, Color-coded maximal ∆F/F of OGB-1 imaged in a L5 pyramidal neuron axon in response to an a-EPSP (five subthreshold current injections at 100 Hz) overlaid with a *z*-projection of biocytin-streptavidin (grey) of the same neuron. White arrowheads indicate regions of interest from which example traces are shown *right*. Scale bar, 20 µm. *Right*, ∆F/F traces from locations specified *left*. For illustrative purposes, ∆F/F traces represent averages of \~400 trials. Top to bottom scale bars, 10 mV, 1 nA, 5% ∆F/F, 100 ms. (**b**) *Left*, higher magnification of the regions of interest shown in a. *Right*, maximal *z*-projection of biocytin-streptavidin (blue) and ßIV spectrin (red). White arrows indicate nodes or Ranvier. Sites with a-EPSP-evoked \[Ca^2+^\]~i~ transients were all positive to ßIV spectrin (*n* = 15 AISs and 23 nodes from *n* = 15 axons). Scale bar, 5 µm. (**c**) Same axon and locations as in a with color-coded maximal ∆F/F in response to an AP. Scale bars, 20 mV, 0.5 nA, 10% ∆F/F, 100 ms and 20 µm. (**d**) *Top*, Population data for peak ∆F/F in response to a-EPSPs in the AIS (*n* = 13), first internode (IN, *n* = 9), the first Node (*n* = 9) and basal dendrite (Dend, *n* = 4), one-way ANOVA with Tukey's multiple comparisons test, p\<0.0001, *Bottom*, peak ∆F/F in response to a single AP in the AIS (*n* = 10), first internode (IN, *n* = 6), the first Node (*n* = 6) and basal dendrite (Dend, *n* = 4), one-way ANOVA with Tukey's multiple comparisons test, p\<0.0001. Open circles represent individual cells and bars show the population mean ± s.e.m. Data available in [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}. See also [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}.\
Figure 1---source data 1.Activity-dependent compartmentalized Ca^2+^ entry in layer five axons.](elife-54566-fig1){#fig1}

Giant saccular organelle amplifies activity-dependent \[Ca^2+^\]~i~ transients in the AIS {#s2-2}
-----------------------------------------------------------------------------------------

The thick-tufted L5 pyramidal neuron AIS contains a unique variant of cisternal organelle characterized by a continuous tubular organization of smooth ER, called the giant saccular organelle ([@bib4]). Cisternal organelles with smooth ER express synaptopodin (synpo), RyR, the IP~3~ receptor 1, and SERCA that are thought to contribute to Ca^2+^ release, buffering and storage ([@bib7]; [@bib53]). We hypothesized that these organelles could generate Ca^2+^-induced Ca^2+^-release, thereby contributing to domain-selective activity-dependent \[Ca^2+^\]~i~ transients ([Figure 1](#fig1){ref-type="fig"}). Triple immunostaining for synpo, Ankyrin G and biocytin confirmed that the cisternal organelle was present along the entire axis of the AIS and spatially overlapped with the subthreshold-evoked \[Ca^2+^\]~i~ transients (*n* = 19; [Figure 2a,b](#fig2){ref-type="fig"}). However, while subthreshold depolarization-induced Ca^2+^ transients were present in the nodes, synaptopodin expression was not detected (*n* = 10 nodes; [Figures 1](#fig1){ref-type="fig"} and [2a](#fig2){ref-type="fig"}). To experimentally test whether AIS Ca^2+^-store release contributes to activity-dependent \[Ca^2+^\]~i~ transients we performed experiments with standard intracellular solution and subsequently re-patched the same cell with a solution containing ryanodine (200 µM, blocking RyR-mediated Ca^2+^ release) and heparin (5 mg/ml, competitively inhibiting IP~3~-evoked Ca^2+^ release; [Figure 2c](#fig2){ref-type="fig"}). Blocking Ca^2+^ release significantly lowered ΔF/F Ca^2+^ peak transients in the AIS, both for the subthreshold- and AP-evoked \[Ca^2+^\]~i~ changes (a-EPSP, 53.2% reduction, p=0.006; AP, 34.3% reduction, p=0.02, one-tailed ratio paired t-tests, *n* = 5; [Figure 2d](#fig2){ref-type="fig"}). Consistent with the AIS-specific location of the giant saccular organelle, store blockers had no effect on AP-evoked Δ\[Ca^2+^\]~i~ in the basal dendrite (p=0.48, *n* = 3; [Figure 2d](#fig2){ref-type="fig"}). Furthermore, since the stores contribute significantly to AIS Ca^2+^ levels, blocking store release could act as a low-pass filter for Ca^2+^ level kinetics, reducing rise and decay times. However, blocking Ca^2+^-store release did not alter the rise- or decay time kinetics in the AIS (τ~act~, p=0.52; τ~de-act~, p=0.18, two-tailed paired *t*-tests, *n* = 5; [Figure 2e](#fig2){ref-type="fig"}). These data suggest that the giant saccular organelle amplifies activity-dependent \[Ca^2+^\]~i~ changes selectively in the AIS.

![Giant saccular organelle amplifies activity-dependent Δ\[Ca^2+^\]~i~ in the AIS.\
(**a**) Example color-coded maximal ∆F/F profile (100 μM OGB-1) in response to a-EPSPs in the AIS (*top*) and Node (*bottom*) compared to *z*-projections for synaptopodin (Synpo, yellow), Ankyrin-G (AnkG, red) and biocytin/streptavidin (blue) of the same axon. White arrows indicate the locations of nodes, in the imaged axon (blue) and a neighboring one, both without synaptopodin. The many small Synpo positive puncta are likely co-localized with subclasses of spines ([@bib12]; [@bib7]). Scale bars, 10 µm and 1 µm. (**b**) The length of synaptopodin fluorescence linearly scales with Ankyrin G length. Red trace, linear regression fit with *y* = 1.005 x -- 0.95, *r*^2^ = 0.966, \*\*\*\*p\<0.0001, *n* = 19. (**c**) Schematic of Ca^2+^-induced Ca^2+^ release by internal ER stores. (**d**) *Top*, example ∆F/F (OGB-1) transients from AIS (left) and dendrite (right) in response to an AP (*V*~m~, black) in control conditions (blue) and re-patched with blockers (green). Scale bars, 10% ∆F/F, 50 mV and 50 ms. *Bottom*, population data of the peak ∆F/F in the AIS in response to a-EPSP (white bars) and AP (black bars) before and after store release block, one-tailed ratio paired t-tests, \*\*p=0.0060, \*p=0.021, *n* = 5. Open circles and connecting lines represent paired recordings from individual cells and bars show the population mean ± s.e.m. (**e**) *Top*, Ca^2+^ transients fitted with a single exponential function (red) to the rise (left) and decay time (right) in response to an AP, red number indicates the τ. *Bottom*, comparison of the rise and decay time (two-tailed paired *t*-tests, τ~act~, p=0.52, τ~de-act~, p=0.18, *n* = 5). Open circles and connecting lines represent paired recordings from individual cells and bars show the population mean ± s.e.m. Data available in [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}.\
Figure 2---source data 1.Giant saccular organelle amplifies activity-dependent Δ\[Ca^2+^\]~i~ in the AIS.](elife-54566-fig2){#fig2}

Ca~V~ channels and NCX have a limited role in activity-dependent Ca^2+^ entry at the AIS {#s2-3}
----------------------------------------------------------------------------------------

Ca^2+^ release from internal stores is likely triggered by Ca^2+^ entry via neuronal voltage-dependent plasmalemmal routes. To test whether AIS \[Ca^2+^\]~i~ changes require Ca^2+^ from the extracellular space, we bath applied 2.5 mM of the Ca^2+^ chelator EGTA which effectively lowered the extracellular Ca^2+^ concentration (\[Ca^2+^\]~o~) from 2 mM to \~437 nM, thereby reducing the driving force for Ca^2+^ (see Materials and methods). Ca^2+^ imaging at the AIS (OGB-1, 100 µM) showed that EGTA almost fully abolished the subthreshold-evoked Δ\[Ca^2+^\]~i~ (90.7% reduction, one-tailed ratio paired t-test, p=0.0031, *n* = 4; [Figure 3a,b](#fig3){ref-type="fig"}). Similarly, the AP-generated Δ\[Ca^2+^\]~i~ was almost extinguished after bath application of EGTA (92.8% reduction, p=0.0011, *n* = 4; [Figure 3a,b](#fig3){ref-type="fig"}).

![Ca~V~ channels play a partial role in activity-dependent Ca^2+^ entry at the AIS.\
(**a**) *Top*, example traces of ∆F/F (100 μM OGB-1) in the AIS evoked by an a-EPSP (left) and AP (right), before (blue) and after (red) bath application of EGTA (2.5 mM). *Bottom*, somatic *V*~m~ and current-clamp protocols. Scale bars bottom right, 20 mV, 100 ms. (**b**) *Left*, population data for the effect of an extracellular Ca^2+^ buffer, Ca~V~ channel blockers and NCX on the peak ∆\[Ca^2+^\]~i~ signal in the AIS in response to an a-EPSP (open bars) and AP stimulation (closed bars). Data are shown as ratio to the pre-drug peak Ca^2+^ responses measured in the same neuron. One-tailed ratio paired t-tests, \*p\<0.05 and \*\*p\<0.01. Open circles represent individual cells and the bars show the mean ± s.e.m. *Right*, schematics of Ca^2+^ entry in the axoplasm via Ca~V~ channels (*top*) or NCX (*bottom*). (**c**) *Top*, example traces of ∆F/F in the AIS evoked by an a-EPSP (left) and AP (right), before (blue) and after (red) bath application of TTA-P2 (1 µM). *Bottom*, somatic *V*~m~ and current-clamp protocols. Scale bar, 20 mV, 100 ms. (**d**) *Top*, example traces of ∆F/F evoked by an AP in the AIS (left) and presynaptic bouton of the same neuron (right), before (blue) and after (red) puff application of ω-conotoxin MVIIC (2 µM). *Bottom*, somatic *V*~m~ and current-clamp protocols. Scale bar, 20 mV, 100 ms. Data available in [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}.\
Figure 3---source data 1.Ca~V~ channels play a partial role in activity-dependent Ca^2+^ entry at the AIS.](elife-54566-fig3){#fig3}

Next, we hypothesized that the transmembrane pathway for Ca^2+^ entry in the AIS during subthreshold stimuli could be explained by the low-voltage gated Ca~V~ channels (T- and R-type). However, bath application of the highly selective T-type (Ca~V~3.1--3) blocker TTA-P2 (1 µM, [@bib23]) or nickel (Ni^2+^, 100 µM) did not significantly reduce Ca^2+^ signals (one-tailed ratio paired *t*-tests; TTA-P2, p=0.17, *n* = 4; Ni^2+^, p=0.063, *n* = 5; [Figure 3b,c](#fig3){ref-type="fig"}). We next blocked R-type Ca~V~ channels, by puffing SNX-482 (500 nM) locally to the AIS, but this did not lead to a reduction in subthreshold \[Ca^2+^\]~i~ rise either (SNX-482, p=0.11, *n* = 3). Furthermore, consistent with their more depolarized voltage range of activation, the L-type channels did not affect subthreshold Δ\[Ca^2+^\]~i~ (20 µM isradipine, p=0.14; 10 µM nimodipine, p=0.41, both *n* = 4; [Figure 3b](#fig3){ref-type="fig"}) and the block of N-type and P/Q-type channels, by local application of ω-conotoxin MVIIC (2 µM) to the AIS, also failed to reduce Ca^2+^ signals (p=0.42, *n* = 5; [Figure 3b](#fig3){ref-type="fig"}). Furthermore, a combined block of T- and L-type channels did not affect the peak ΔF/F in the AIS (TTA-P2 and isradipine, p=0.12, *n* = 3; [Figure 3b](#fig3){ref-type="fig"}).

Although application of the T-type blockers TTA-P2 and Ni^2+^ was ineffective to block subthreshold \[Ca^2+^\]~i~ rise, in the same neurons it did reduce the peak ΔF/F evoked by a single AP by almost 20% (TTA-P2, 18.7%, p=0.021, *n* = 4; Ni^2+^, 19.7% block, p=0.013, *n* = 5; [Figure 3b,c](#fig3){ref-type="fig"}). In addition, isradipine reduced the AP-evoked Δ\[Ca^2+^\]~i~ in the AIS by 14.9% (isradipine, p=0.0070, *n* = 4) and the alternative L-type blocker nimodipine showed a non-significant blocking trend (nimodipine, p=0.060, *n* = 4; [Figure 3b](#fig3){ref-type="fig"}). A combined application of T- and L-type channel blockers (1 µM TTA-P2 and 20 µM isradipine) caused a 27.2% reduction of peak ΔF/F, showing a sublinear summation of two blocking agents (TTA-P2 and isradipine, p=0.0071, *n* = 5; [Figure 3b](#fig3){ref-type="fig"}). In contrast, the R-type Ca~V~ channel blocker SNX-482 (500 nM) did not reduce the AP-evoked Δ\[Ca^2+^\]~i~ (SNX-482, p=0.29*, n* = 3; [Figure 3b](#fig3){ref-type="fig"}). Local application of the ω-conotoxin MVIIC (2 µM) showed a non-significant trend to block the peak ΔF/F (6.8%, p=0.064, *n* = 5; [Figure 3b](#fig3){ref-type="fig"}). As a positive control experiment, we imaged a collateral bouton of the same neuron and used local application of ω-conotoxin MVIIC which almost completely abolished the peak ΔF/F by 91.5%, consistent with the presence of N- and P/Q-type Ca~V~ channel subtypes in presynaptic terminals (p=0.021, *n* = 3; [Figure 3b](#fig3){ref-type="fig"}). Finally, given the unexpected remaining \[Ca^2+^\]~i~ transients in the AIS in the presence of Ca~V~ channel blockers, we hypothesized that NCX may contribute to activity-dependent \[Ca^2+^\]~i~ increase in the AIS. At the resting membrane potential NCX exports Ca^2+^ from the cytoplasm to maintain \[Ca^2+^\]~i~ near \~50 nM, however Na^+^ entry may promote instantaneous Ca^2+^ influx by a reverse mode of operation ([@bib91]; [@bib81]; [Figure 3b](#fig3){ref-type="fig"}). To examine its contribution, we pharmacologically blocked NCX by combined bath application of KB-R7943 (20 µM) and SN-6 (10 µM). The results showed, however, no change in the subthreshold nor AP-evoked Δ\[Ca^2+^\]~i~ (two-tailed ratio paired t-tests, a-EPSP, p=0.16; AP, p=0.13, *n* = 5, respectively; [Figure 3b](#fig3){ref-type="fig"}).

In summary, these data show that while transmembrane Ca^2+^ influx from the extracellular space is required for activity-evoked Δ\[Ca^2+^\]~i~, none of the Ca~V~ channels played a role in the subthreshold depolarization, whereas T- and L-type Ca~V~ channels partially contributed to the AP-evoked influx.

Subthreshold- and AP-evoked Ca^2+^ entry at the AIS requires TTX-sensitive channels {#s2-4}
-----------------------------------------------------------------------------------

What could be the source of the remaining component of Ca^2+^ influx at the AIS? Both in hippocampal neurons and heart muscle cells, Ca^2+^ currents have been described which are not blocked by Ni^2+^ nor by other known Ca~V~ channel antagonists, but instead are sensitive to the highly selective Na~V~ channel blocker (TTX), and therefore called *I*~Ca(TTX)~ ([@bib3]; [@bib1]). In Na^+^-free extracellular solution *I*~Ca(TTX)~ resembles the Na^+^ current and activates at potentials as negative as --70 mV while peaking at --30 mV ([@bib3]). To examine the presence of *I*~Ca(TTX)~ in L5 axons we took advantage of the low-affinity indicator Oregon Green BAPTA 5N (OGB-5N, 1 mM; [Figure 4a](#fig4){ref-type="fig"}), which gives smaller fluorescent signals but is linear over a wider range of \[Ca^2+^\]~i~ compared to OGB-1 (*K*~d ~20 µM vs. 170 nM, respectively). We used the voltage-clamp configuration and injected depolarizing ramps of 50 ms with increasing slopes (from 0.0 to 0.55 mV ms^--1^) with a maximum peak at \~95% of the AP threshold ([Figure 4b](#fig4){ref-type="fig"}), thereby studying the same depolarization range and duration as the a-EPSPs used in [Figures 1](#fig1){ref-type="fig"}--[3](#fig3){ref-type="fig"}. The results showed that Ca^2+^ influx was strongly compartmentalized to the AIS and nodal axolemma ([Figure 4a](#fig4){ref-type="fig"}) consistent with the a-EPSP evoked OGB-1 transients ([Figure 1](#fig1){ref-type="fig"}). Remarkably, bath application of TTX almost completely abolished \[Ca^2+^\]~i~ elevations, even at depolarizations above the AP threshold (at --54.5 mV, 92.8% block, Cohen's *d*: 1.88, two-way ANOVA, p\<0.0001, *n* = 4; [Figure 4b,c](#fig4){ref-type="fig"}). As an alternative to TTX we used the quaternary amine Na~V~ channel inhibitor QX-314, which plugs the open state of the Na~V~ channel from the internal side. Similar to TTX, with 6 mM QX-314 added to the pipette solution voltage ramps did not evoke Ca^2+^ transients (at --54.5 mV, 94.8% block, Cohen's *d*: 1.92, control vs. QX-314, p\<0.0001, *n* = 4, TTX vs. QX-314, p=0.97, *n* = 4; [Figure 4c](#fig4){ref-type="fig"}). Although QX-314 at this concentration has been reported to also block voltage-gated Ca^2+^ currents ([@bib84]), subthreshold-evoked \[Ca^2+^\]~i~ was not mediated by Ca~V~ channels ([Figure 3b](#fig3){ref-type="fig"}). The near complete block by two distinct Na~V~ channel blockers therefore indicates an important role of Na~V~ channels in mediating subthreshold axonal Ca^2+^ influx.

![Subthreshold \[Ca^2+^\]~i~ changes are TTX sensitive.\
(**a**) Example image of color-coded maximal ∆F/F (1 mM OGB-5N) along the proximal axon in response to a voltage ramp from --78.5 mV to maximally --54.5 mV. Acquisition rate was 125 Hz. The color-coded image is overlaid with a maximal *z*-projection of a confocal scan of biocytin/streptavidin staining (grey) of the same axon. Note the compartmentalized Ca^2+^ influx at the AIS and node (indicated by a white arrow). Scale bar, 20 µm. (**b**) Example traces of OGB-5N ΔF/F reveal increasing Ca^2+^ responses to voltage ramps with increasing incline in control (*left*) but not in TTX (1 µM, *right*). Traces filtered with one-pass binomial (three point). Scale bars, 1% ∆F/F, 10 mV and 50 ms. (**c**) Population data for maximal OGB-5N ΔF/F versus voltage ramp peaks in control (closed circles, *n* = 4), in TTX (open circles, *n* = 4) or QX-314 (open triangles, 6 mM, *n* = 4). Two-way ANOVA with Tukey's multiple comparisons test, \*\*p\<0.01, \*\*\*\*p\<0.0001. AP threshold is indicated with a gray line. Data are shown as mean ± s.e.m. Data available in [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}.\
Figure 4---source data 1.Subthreshold \[Ca^2+^\]~i~ changes are TTX sensitive.](elife-54566-fig4){#fig4}

We next investigated whether Na~V~ channels also contribute to AP-evoked Δ\[Ca^2+^\]~i~ ([Figure 5a](#fig5){ref-type="fig"}). To dissociate a putative role of Na~V~ channels to pass Ca^2+^ ions from generating the AP depolarization of \~100 mV we first imaged Ca^2+^ at the AIS in current-clamp, subsequently applied 1 µM TTX and imaged Ca^2+^ transients evoked by the recorded AP waveform injected as a voltage command ('AP-clamp'). The results showed a near complete abolishment of Δ\[Ca^2+^\]~i~ in the presence of TTX (one-way ANOVA with Tukey's multiple comparisons test, CC vs. VC, 89.5% reduction, p\<0.0001, *n* = 7; [Figure 5a,b](#fig5){ref-type="fig"}). However, this \[Ca^2+^\]~i~ peak amplitude reduction could also be due to an incomplete voltage- and space-clamp of the AIS for fast voltage transients. The small diameter of the axon has a high axial resistance, acting as a low-pass filter for the antidromic AIS action potentials ([@bib39]) which also may attenuate the orthodromic voltage spread into the axon. To examine the possibility that axonal APs are attenuated in the somatic AP clamp configuration, we optically recorded JPW3028, a fast fluorescent voltage indicator that remains stable over long recording periods and is highly linear over a large voltage range (\~250 mV, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Consistent with the voltage loss, when we injected the AP-clamp in the soma in the presence of TTX and optically recorded *V*~m~ in the AIS, we observed a significant \~2 fold reduction in the AP peak amplitude (one-way ANOVA with Tukey's multiple comparisons test, VC vs. CC, p=0.014; [Figure 5a,c](#fig5){ref-type="fig"}). To restore peak depolarization in the presence of TTX and reliably compare the Ca^2+^ transients evoked by equal depolarization, we doubled the amplitude of the somatic AP-clamp (VC ×2). With this protocol both the peak depolarization and AP half-width in the AIS were indistinguishable from the control APs (peak JPW, VC ×2 vs. CC, one-way ANOVA with Tukey's multiple comparisons test, p=0.75, *n* = 4, [Figure 5c](#fig5){ref-type="fig"}, half-width in JPW, VC ×2 vs. CC, one-way ANOVA with Tukey's multiple comparisons test, p=0.36, *n* = 4, not shown). TTX blocked 65.5% of the AP-evoked Δ\[Ca^2+^\]~i~ (peak OGB-5N, Cohen's *d*: 5.49, VC ×2 vs. CC, p\<0.0001, *n* = 8; [Figure 5b](#fig5){ref-type="fig"}). Taken together, these data suggest that a large fraction of both subthreshold-depolarization and AP-evoked Ca^2+^ ions enter the axoplasm through TTX-sensitive channels at the AIS.

![AP-evoked \[Ca^2+^\]~i~ changes are TTX sensitive.\
(**a**) *Left*, schematic of the experimental setup; electrophysiological recording from the soma and fluorescence recording from AIS. *Right*, example traces from electrophysiology (recorded traces in black, applied commands in green), ∆F/F JPW3028 (red) for voltage imaging and ∆F/F OGB-5N (blue) for Ca^2+^ imaging. Left panel shows example traces from a current clamp recording, middle panel was performed in AP-clamp in the presence of TTX (1 µM) and right panel was performed in AP-clamp scaled two-fold (VC ×2) in the presence of TTX. The JPW3028 and OGB-5N experiments were performed in separate cells. Scale bars from top to bottom, 100 mV, 5 nA, 5 ms, 2% ∆F/F and 5% ∆F/F. (**b**) Peak OGB-5N ΔF/F in response to an AP (*n* = 8), AP clamp + TTX (VC, *n* = 7) and double AP clamp + TTX (VC ×2, *n* = 8). One-way ANOVA with Tukey's multiple comparisons test, \*\*\*p=0.0005, \*\*\*\*p\<0.0001, *n* = 8. Circles and connecting lines represent paired recordings in individual cells and bars show the population mean ± s.e.m. (**c**) Peak JPW3028 ΔF/F in response to an AP (*n* = 9), AP clamp + TTX (VC, *n* = 7) and double AP clamp + TTX (VC ×2, *n* = 4). One-way ANOVA with Tukey's multiple comparisons test, \*p=0.014. Circles and connecting lines represent paired recordings in individual cells and bars show the population mean ± s.e.m. Data available in [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}. See also [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}.\
Figure 5---source data 1.AP-evoked \[Ca^2+^\]~i~ changes are TTX sensitive.](elife-54566-fig5){#fig5}

Axonal \[Ca^2+^\]~i~ follows gating kinetics of Na~V~ channels {#s2-5}
--------------------------------------------------------------

Whether *I*~Ca(TTX)~ is carried by a specific TTX-sensitive Ca~V~ channel or reflects Ca^2+^ permeating directly through the Na~V~ channel remains debated ([@bib75]; [@bib27]; [@bib43]; [@bib22]; [@bib37]). We hypothesized that if Ca^2+^ ions enter the AIS cytoplasm by flowing through Na~V~ channels, *I*~Ca(TTX)~ should reflect the time course of *I*~Na~. To measure submillisecond rapid events with fluorescence in the small axon (diameter \~1.5 µm), we optimized multiple imaging parameters enabling the acquisition of fluorescence at 20 kHz (see Materials and methods). Using a Na^+^-sensitive indicator (sodium-binding benzofuran isophthalate, SBFI, 1 mM) in combination with OGB-5N (1 mM) showed that the two indicators were indistinguishable in their rising phase during an AP, suggesting that Ca^2+^ entry at the AIS may be as rapid as Na^+^ entry ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}).

In order to quantify the kinetics of *I*~Na~ and *I*~Ca~ more directly, we next used a voltage-clamp approach. Near \~20°C and --40 mV, Na~V~ channels open at least one order of magnitude faster compared to the T-type Ca~V~ channels (\~200 µs \[[@bib78]\] vs. \~5 ms \[[@bib69]\], respectively) which may be sufficiently different to compare against the kinetics of optically recorded \[Ca^2+^\]~i~ at the AIS. To determine the specific activation kinetics of *I*~Na~ and T-type *I*~Ca~ (*I*~CaT~) in L5 pyramidal neurons we measured total inward current (*I*~Na~ + *I*~Ca~,) by depolarizing the soma with a step to --35 mV and pharmacologically isolated Na^+^ and Ca^2+^ current components by bath application of 1 µM TTX or 100 µM Ni^2+^, respectively ([Figure 6a](#fig6){ref-type="fig"}). The activation time constant of the total inward current was identical to *I*~Na~ (single exponential fit τ~total~ = 438.2 µs vs. τ~Na~ = 440.3 µs, one-way ANOVA with Tukey's multiple comparison test, p\>0.999, *n* = 6), whereas the total current was substantially faster in comparison to *I*~CaT~ (τ~total~ = 438.2 µs vs. τ~CaT~ = 4.8 ms, p\<0.0001, *n* = 5; [Figure 6a](#fig6){ref-type="fig"}). The initial fraction of the inward current was thus primarily generated by *I*~Na~. The large difference in gating could provide a temporal window to distinguish Ca^2+^ entry via Na~V~ channels or T-type Ca~V~ channels. Theoretical and experimental work show that low-affinity Ca^2+^ indicators, like OGB-5N, are capable of tracking rapidly activating Ca^2+^ currents when imaged at high speed: the first time derivative of ΔF/F (dΔF/F dt^--1^) overlaps with electrically recorded *I*~Ca~, providing a mean to optically resolve the time course of *I*~Ca~ ([@bib74]; [@bib50]; [@bib2]).

![Temporal derivative of AIS \[Ca^2+^\]~i~ mirrors the opening kinetics of Na~V~ channels.\
(**a**) *Top to bottom*, total inward current in response to a voltage-clamp step to --35 mV (blue) and after application of 1 μM TTX (black), *I*~Na~; the difference between the total current and the TTX-sensitive current, *I*~CaT~, obtained after application of 100 μM Ni^2+^, voltage clamp protocol (green). Scale bars, 10 nA and 50 ms. (**b**) *Top to bottom*: ΔF/F OGB-5N of an AIS imaged at 20 kHz before and after application of 1 μM TTX, the electrically recorded somatic *I*~Na~ of the same neuron overlaid with the first temporal derivative of ΔF/F (--d(ΔF/F) dt^-1^) representing *I*~Ca_opt~, voltage clamp protocol. Optically and electrically recorded traces filtered with a 3-point binomial filter for 100 iterations. Red arrows indicate the rapid component visible in the ΔF/F and in the overlaid *I*~Na~ and *I*~Ca_opt~. Scale bars, 20% ΔF/F, 10%^--1^/6.3 nA and 50 ms. (**c**) *Top to bottom: I*~Ca_opt~, *I*~Na~ and *I*~CaT~ fit with a Boltzmann sigmoid function (red). Slope values are indicated. Scale bar, 5 ms. (**d**) Population data for the slope values for *I*~Na~ (*n* = 17), *I*~Ca_opt~ (*n* = 10) and *I*~CaT~ (*n* = 5). One-way ANOVA with Tukey's multiple comparisons test, \*\*\*\*p\<0.0001. Open circles represent individual cells, bars indicate the population mean ± s.e.m. Data available in [Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"}. See also [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}.\
Figure 6---source data 1.Temporal derivative of AIS \[Ca^2+^\]~i~ mirrors the opening kinetics of Na~V~ channels.](elife-54566-fig6){#fig6}

Imaging OGB-5N (1 mM) at 20 kHz in the AIS we observed that ΔF/F comprised of two separate time courses, a fast initial rise followed by a slower rising phase ([Figure 6b](#fig6){ref-type="fig"}). Both components were almost completely abolished by TTX, leaving only a small transient reflecting putatively *I*~CaT~ (*n* = 6). We quantitatively compared the activation time constants of *I*~Na~, *I*~Ca_opt~ (dΔF/F dt^--1^) and *I*~CaT~ by resampling the electrically recorded *I*~Na~ and *I*~CaT~ to 20 kHz and filtering both electrical and optical traces identically (see Materials and methods). Multiple hallmarks of *I*~Na~ matched with *I*~Ca_opt~: both traces showed a rapid inward component, followed by inactivation and a persistent component ([Figure 6b,c](#fig6){ref-type="fig"}). In comparison, *I*~CaT~ lacked both the rapid activation and inactivation time constants ([Figure 6a,c](#fig6){ref-type="fig"}). Given the lower signal-to-noise ratio in the optical traces we fitted Boltzmann sigmoid functions to the rising phase to compare the slopes of the optically and electrically recorded currents ([Figure 6c](#fig6){ref-type="fig"}). The average slope of *I*~Ca_opt~ was significantly faster compared to the activation of *I*~CaT~ (\~500 µs vs. \~2.5 ms, respectively, one-way ANOVA with Tukey's multiple comparison test, p\<0.0001) and slower compared to *I*~Na~ (\~500 µs vs. \~200 µs, *I*~Ca_opt~ vs. *I*~Na~p\<0.0001; [Figure 6c,d](#fig6){ref-type="fig"}). The small difference between *I*~Na~ and *I*~Ca_opt~ may be explained by the equilibration time of OGB-5N (\~200 µs) ([@bib2]), local differences between Na~V~ channels in the soma and AIS or the presence of Ca^2+^-store release in the AIS. Together, the findings indicate that the current mediating \[Ca^2+^\]~i~ at the AIS resembles Na~V~ channel kinetics.

Calcium influx through Na~V~1.2 channels {#s2-6}
----------------------------------------

The results suggest that Ca^2+^ ions could enter the cytoplasm by permeation through the Na~V~ channel pore. Previous studies showed Ca^2+^ influx through the cardiac Na~V~1.5 channel ([@bib27]; [@bib37]). To examine whether Na~V ~channel isoforms of the axon initial segment also enable Ca^2+^ influx we performed experiments in HEK-293 cells which were transfected with the human gene *SCN2A* encoding Na~V~1.2 channel with auxiliary β1 and β2 subunits and EGFP tag (Materials and methods; [Figure 7a](#fig7){ref-type="fig"}). Whole-cell recording revealed Na^+^ currents in EGFP^+^ cells but not in non-transfected cells (average peak current density --115.7 ± 28.4 pA/pF, *n* = 10 vs. --3.7 ± 1.9 pA/pF at --20 mV, *n* = 5, respectively; [Figure 7b](#fig7){ref-type="fig"}). The inward currents were completely abolished by 1 µM TTX (96.1 ± 1.3%, *n* = 7, one-tailed Wilcoxon matched-pairs signed rank test, p=0.0078, [Figure 7c](#fig7){ref-type="fig"}) and the voltage-dependence of activation and inactivation revealed midpoints at --25.4 ± 2.1 mV and --74.1 ± 3.9 mV, respectively (*n* = 10, [Figure 7d,e](#fig7){ref-type="fig"}), consistent with previous work ([@bib10]), indicating a highly selective expression of Na~V~1.2 channels. Next, we filled the transfected cells with 100 µM OGB-1 and imaged the fluorescence changes in response to a train of depolarizing pulses (200 Hz for 1 s, --120 to --30 mV steps; [Figure 7f](#fig7){ref-type="fig"}). We observed an increase in ΔF/F in every EGFP^+^ cell, indicating an influx of Ca^2+^ (average peak 0.46 ± 0.18% ΔF/F, range: 0.06--1.4% ΔF/F, *n* = 7; [Figure 7f--h](#fig7){ref-type="fig"}). To test whether the \[Ca^2+^\]~i~ increase required Na~V~ channel opening we bath applied TTX (1 µM), revealing a significant decrease in the peak ΔF/F (92.1 ± 3.8% reduction, one-tailed Mann Whitney test, p=0.012, *n* = 4; [Figure 7h](#fig7){ref-type="fig"}). The results indicate that molecular expression and opening of Na~V~1.2 channels suffices to mediate transmembrane Ca^2+^ influx.

![Na~V~1.2 channels mediate a Ca^2+^ influx.\
(**a**) Combined brightfield and fluorescence image of a whole-cell recording from a SCN2A-EGFP^+^ HEK-293 cell (green). Scalebar, 10 μm. (**b**) Example traces of *I*~Na~ recorded in response to depolarizing voltage command potentials (*bottom*) for a non-transfected (*top*) and SCN2A-EGFP^+^ cell (*middle*), scale bars indicate 0.5 nA and 5 ms. (**c**) Peak *I*~Na~ traces before (black) and after TTX application (red) in response to a depolarizing voltage step (*bottom*), scale bars indicate 100 pA and 10 ms. (**d**) Example current traces of steady-state inactivation (*left*) and activation protocols (*right*), scale bars indicated 100 pA and 5 ms. (**e**) Population data for steady-state activation and inactivation curves, circles and error bars indicate mean ± s.e.m. Lines represent Boltzmann fits to the mean data. (**f**) Schematic of the experiment: a SCN2A-EGFP^+^ HEK-293 cell was recorded in voltage-clamp and filled with OGB-1 (0.1 mM) after which a train of depolarizing pules (--120 to --30 mV, 200 Hz, 1 s) was applied, *top to bottom*, ΔF/F before and after bath application of 1 μM TTX (blue), the recorded currents and voltage command potentials, *right*, magnification of the first three action currents, scale bars from top to bottom represent 1% ΔF/F, 0.5 nA, 100 mV, 500 ms and 10 ms. (**g**) Color-coded average ΔF/F of 100 frames before onset (*left*) and at the end (*right*) of the voltage command, scale bar indicates 10 μm. (**h**) OGB-1 ΔF/F is significantly higher in control (*n* = 7) than after application of TTX (*n* = 4), one-tailed Mann Whitney test, p=0.0121. Data available in [Figure 7---source data 1](#fig7sdata1){ref-type="supplementary-material"}.\
Figure 7---source data 1.Na~V~1.2 channels mediate a Ca^2+^ influx.](elife-54566-fig7){#fig7}

Estimating Ca^2+^ conductivity of Na~V~ channels with computational modeling {#s2-7}
----------------------------------------------------------------------------

Our findings are in agreement with the depolarization-induced Ca^2+^ entry in the squid axon which is tetrodotoxin (TTX)-sensitive and reflected a 1% conductivity of Na~V~ channels for Ca^2+^ ions ([@bib6]). To estimate the conductivity ratios (*g*~Ca~/*g*~Na~) in L5 axons we performed computational simulations. Ca^2+^ entry through Na~V~ channels was implemented by adding an ohmic Ca^2+^ ion mechanism into a mathematical 8-state Na~V~ channel model that calculated the current carried by Ca^2+^ (*I*~Ca(Na)~) and Na^+^ (*I*~Na~) (see Materials and methods). A single compartment containing *I*~Na~ and *I*~Ca(Na)~ together with high voltage-gated and T type-gated Ca~V~ channel models (*I*~CaH~ and *I*~CaT~, respectively) showed that with an axonal AP waveform *I*~Ca(Na)~ is activated during the first microseconds of AP onset, rapidly inactivates and is temporally separated from *I*~CaH~ and *I*~CaT~ ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}). Next, to estimate the *g*~Ca~/*g*~Na~ we made a multicompartmental model of a L5 pyramidal neuron ([Figure 8a](#fig8){ref-type="fig"}, including detailed reconstructions of the AIS and nodal domains (see Figure 2a within [@bib39]). Based on multiple experimentally recorded parameters we constrained the model AP and found that a peak conductance density of Na~V~ channels of 16,000 and 850 pS µm^--2^ in the AIS and soma, respectively, reproduced the recorded AP and matched with AP-evoked Δ\[Na^+^\]~i~ imaged in the AIS (see Materials and methods and [Figure 8a](#fig8){ref-type="fig"}). Subsequently, \[Ca^2+^\]~i~ was simulated based on mathematical equations representing Ca^2+^ diffusion and extrusion, endogenous stationary Ca^2+^ buffers (taken together as κ~s~) and was supplemented with the buffering capacities of the specific Ca^2+^ indicators ([@bib31]) (see Materials and methods). The Ca^2+^ extrusion threshold and rates were adjusted to approximate the experimentally imaged peak and decay time course of measured OGB-5N ΔF/F in the AIS ([Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}). To determine the absolute rise in \[Ca^2+^\]~i~ produced exclusively by Na~V~ channels, we performed additional experiments in which we imaged \[Ca^2+^\]~i~ while blocking Ca~V~ channels that contributed to AP-evoked Δ\[Ca^2+^\]~i~: T- and L-type calcium channels (TTA-P2 and isradipine, respectively, see [Figure 3b](#fig3){ref-type="fig"}). Using calibrated ratiometric bis-Fura-2 (200 μM) imaging, we found that during 1 AP, Ca^2+^ entry though Na~V~ channels induces a peak Δ\[Ca^2+^\]~i~ of 55.6 nM (*n* = 4; [Figure 8b](#fig8){ref-type="fig"}, [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}). Since \~35% of AP-evoked Δ\[Ca^2+^\]~i~ is caused by internal store amplification ([Figure 2d](#fig2){ref-type="fig"}) \~36 nM is mediated by transmembrane Ca^2+^ entry via Na~V~ channels ([Figure 8b](#fig8){ref-type="fig"}). We subsequently simulated these experiments in the multicompartmental model by removing Ca~V~ channels and including the buffering properties of 200 µM bis-Fura-2. Varying endogenous buffering (κ~s~) between 1 and 100 we updated *g*~Ca~/*g*~Na~ to obtain a 36 nM rise of free \[Ca^2+^\]~i~ at the AIS. A κ~s~ of \~100 corresponds to dendritic buffering capacities ([@bib25]), while axonal buffering capacities are reported to be lower (10--40, [@bib54]; [@bib51]; [@bib29]). When changing κ~s~ between 10--40 the *g*~Ca~/*g*~Na~ ratio was 0.38% (κ~s~ = 10: 0.37%, κ~s~ = 40: 0.39%; [Figure 8c](#fig8){ref-type="fig"}).

![Computational simulation of Ca^2+^ conductivity by Na~V~ channels predicts a conductivity ratio of 0.38%.\
(**a**) *Left*, morphology of the conductance-based multi-compartmental model. *Right*, Na~V~ channel density in the AIS was estimated by optimizing to Δ\[Na^+^\]~i~, *V*~m~ (*top*) and phase-plane plot (*bottom*) in simulation (black) to the experimental data (gray). Scale bars, 200 µm, 20 mV and 0.5 ms. (**b**) Example trace of calibrated ratiometric imaging of bis-Fura2 to measure absolute changes in Δ\[Ca^2+^\]~i~ in response to a single AP (bottom), the experiment was performed in the presence of T- and L-type CaV blockers, so Δ\[Ca^2+^\]~i~ is mediated by Na~v~ channels (red) and amplified by internal store release (35%, green), scale bars indicate 10 nM, 100 mV and 10 ms. (**c**) Dependence of Na~V~-mediated peak AP Δ\[Ca^2+^\]~i~ on conductance ratio (*g*~Ca~/*g*~Na~) for varying endogenous buffer capacities (κ~s~ = 1--100). Δ\[Ca^2+^\]~i~ was measured and modeled in a cell with 200 μM bis-Fura-2 present and T- and L-type Ca~V~ channels blocked. See also [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"} and [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}.](elife-54566-fig8){#fig8}

Spatiotemporal distribution of Ca^2+^ entry routes under physiological conditions {#s2-8}
---------------------------------------------------------------------------------

Using the 0.38% conductivity ratio we next evaluated how Ca^2+^ currents through Na~V~ and Ca~V~ channels spatiotemporally varied across the neuronal compartments without the buffering capacities of externally applied Ca^2+^ dyes ([Figure 9a,b](#fig9){ref-type="fig"} and [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}). The simulations showed that the Δ\[Ca^2+^\]~i ~from one AP reached a peak concentration of \~800 nM in the AIS ([Figure 9a,b](#fig9){ref-type="fig"}). Due to the high density of Na~V~ channels in the AIS they contribute to the majority of Δ\[Ca^2+^\]~i~ and cause a rise of \[Ca^2+^\]~i~ within submillisecond from the start of the AP (450 nM within \<150 µs from AP threshold, red arrow in [Figure 9b](#fig9){ref-type="fig"}). These results are likely to provide an underestimate of the total Δ\[Ca^2+^\]~i~ since in the model Ca^2+^ release from giant saccular organelle was not simulated, which would result in a total AP-evoked Δ\[Ca^2+^\]~i~ of \~1.2 µM. In the basal dendritic branches the AP has a slower rise time and broader half-width, causing dendritic \[Ca^2+^\]~i~ to accumulate slower and to higher concentrations, consistent with our experimental findings ([Figure 1](#fig1){ref-type="fig"}). Because the dendritic Na~V~ channel density is substantially lower, their contribution to the total \[Ca^2+^\]~i~ is negligible. The distinct contribution of Na~V~ and Ca~V~ channels to \[Ca^2+^\]~i~ is clearly visible when comparing the different Ca^2+^ currents in the AIS, showing that the majority of the total *I*~Ca~ during an AP is carried by *I*~Ca(Na)~ ([Figure 9c](#fig9){ref-type="fig"}). Simulations predict that the *I*~Ca(Na)~ rapidly inactivates during the AP while *I*~Ca~ activates more slowly and has an incomplete inactivation during the AP repolarization, likely becoming the dominant contribution to \[Ca^2+^\]~i~ during the afterdepolarization and high-frequency spike generation ([Figure 9c](#fig9){ref-type="fig"} and [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}).

![Na~V~ channels produce submillisecond near-micromolar \[Ca^2+^\]~i~ at the AIS.\
(**a**) Color coded shape plot of simulated \[Ca^2+^\]~i~ in the axon, dendrites and soma activated by an AP in current clamp without Ca^2+^ indicator. (**b**) The modeled \[Ca^2+^\]~i~ in the AIS, Soma and Dendrite (locations specified in **a**). The total \[Ca^2+^\]~i~ (black) is divided in a Na~V~ (red) and Ca~V~ (green) channel mediated fraction. *Bottom, V*~m~ in the same compartments. Scale bars, 400 nM for all \[Ca^2+^\]~i~ plots, 50 mV and 1 ms. (**c**) *Top, I*~Ca~ in response to an AP (*bottom*) in the AIS. *Middle*, *I*~Ca~ on expanded scale. Ca^2+^ extrusion contributes to *I*~Ca~ total, but is not shown. Scale bars bottom, 50 mV and 1 ms. (**d**) *Top*, example traces of somatic APs in control (black) and after bath application of TTA-P2 and Isradipine (green, left) and EGTA (red, right). Resting membrane potential and AP voltage threshold are indicated by the dotted grey lines. Red arrows indicate the significant changes in ADP (with TTA-P2 + Isradipine) and AP width and AHP (with EGTA). Capacitance transients are removed for clarity. Scale bars indicate 50 mV, 2.5 nA, 1 ms. *Bottom*, population data of AP half-width before and after blocking T-- and L--type Ca~V~ channels (*left, p*=0.61, two-tailed paired t-test, *n* = 5) and before and after preventing Ca^2+^ influx by bath application of EGTA (*right*, \*p=0.035, two-tailed paired t-test, *n* = 4), see also [Table 1](#table1){ref-type="table"}. (**e**) Schematic of Ca^2+^ permeation through a Na~V~ channel activating a Ca^2+^--dependent BK channel.](elife-54566-fig9){#fig9}

Our experiments and computational simulations show that \[Ca^2+^\]~i~ changes mediated by Ca~V~ or Na~V~ channels act at distinct spatiotemporal scales. To experimentally test the differential impact of Ca^2+^ influx on the AP waveform, we analyzed the somatically recorded APs when using distinct blockers most effective in modulating \[Ca^2+^\]~i~ in the AIS ([Figure 3](#fig3){ref-type="fig"}). Blocking both T- and L-type Ca~V~ channels, contributing to \~27% to AP-evoked Ca^2+^ at the AIS ([Figure 3](#fig3){ref-type="fig"}), significantly reduced the afterdepolarization and showed a trend to reduce the afterhyperpolarization (ADP, p=0.039 and AHP, p=0.055, respectively, two-tailed paired t-tests, *n* = 5), without affecting other AP properties (p\>0.30; [Figure 9d](#fig9){ref-type="fig"} and [Table 1](#table1){ref-type="table"}). In contrast, when lowering \[Ca^2+^\]~o~ with EGTA, which abolished all AIS Ca^2+^ influx ([Figure 3](#fig3){ref-type="fig"}), the AP half-width significantly increased and the AHP was reduced (AP half-width, p=0.035 and AHP, p=0.043, two-tailed paired t-tests, *n* = 4; [Figure 9d](#fig9){ref-type="fig"}, [Table 1](#table1){ref-type="table"}). These results are consistent with the temporal differences in AP-evoked AIS \[Ca^2+^\]~i~ and suggest that Na~V~-mediated Ca^2+^ entry may act to open BK~Ca~ channels ([Figure 9e](#fig9){ref-type="fig"}), thereby driving K^+^ efflux and facilitating axonal AP repolarization.

###### Effect of Ca^2+^ entry on AP waveform.

Table 1---source data 1.Effect of Ca^2+^ entry on AP waveform.

  --------------------------------------------------------------------------------------------------------------------
                             RMP\           AP threshold\   AP amplitude\   AP half-width\   AHP\         ADP\
                             (mV)           (mV)            (mV)            (μs)             (mV)         (mV)
  -------------------------- -------------- --------------- --------------- ---------------- ------------ ------------
  Control                    --77.4 ± 2.5   --67.1 ± 3.0    110.9 ± 12.5    612.7 ± 24.7     5.6 ± 2.1    7.6 ± 2.5

  TTA-P2 + isradipine        --76.0 ± 2.9   --65.0 ± 4.1    109.3 ± 3.3     634.5 ± 49.6     3.2 ± 2.9    4.6 ± 3.3

  Paired t-tests (*n* = 5)   p=0.32         p=0.30          p=0.33          p=0.61           p=0.055      p=0.039\*

  Control                    --70.4 ± 1.6   --59.3 ± 3.9    102.4 ± 1.8     753.8 ± 45.9     3.7 ± 3.8    6.5 ± 3.4

  EGTA                       --71.8 ± 3.6   --65.4 ± 1.8    103.5 ± 2.4     1031.5 ± 39.6    25.5 ± 4.3   11.7 ± 1.5

  Paired t-tests (*n* = 4)   p=0.69         p=0.19          p=0.27          p=0.035\*        p=0.043\*    p=0.17
  --------------------------------------------------------------------------------------------------------------------

Overview of mean and s.e.m. of AP properties compared between control and toxin experiments recorded at the soma. RMP, resting membrane potential, AHP, fast afterhyperpolarization, ADP, afterdepolarization. The APs were elicited by large and brief current injections (\~6 nA for 0.5 ms) to obtain temporally aligned APs between trials and image OGB-1 fluorescence ([Figure 3](#fig3){ref-type="fig"}). AP amplitude, AHP and ADP were measured relative to the AP threshold. If the AHP or ADP was not detectable as a local peak, the membrane potential at the time point as in control was used (see EGTA example [Figure 9d](#fig9){ref-type="fig"}). *P* values are results of two-tailed paired *t*-tests before and after toxin application. Data available in [Table 1---source data 1](#table1sdata1){ref-type="supplementary-material"}.

Discussion {#s3}
==========

In the present study we identified Ca^2+^ permeation through Na~V~ channels as a source for activity-dependent Ca^2+^ entry in mammalian axons. The findings were supported by independent and converging lines of evidence, ranging from anatomical compartmentalized \[Ca^2+^\]~i~ transients at sites with high Na~V~ channel densities, a pharmacological block by TTX, an overlap of optically recorded *I*~Ca~ with Na~V~ channel gating and molecular evidence for Ca^2+^ influx mediated by the Na~V~1.2 channel. In axonal domains Na~V~ channels are thus not only involved in electrically generating the upstroke of the action potential, but also contribute to cytoplasmic Ca^2+^ signaling.

Ca^2+^ entry in the L5 pyramidal neuron AIS was in part mediated by T- and L-type Ca~V~ channels ([Figure 3](#fig3){ref-type="fig"} and [Figure 5](#fig5){ref-type="fig"}) in keeping with previous studies showing that Ca~V~ channel subtypes mediate activity-dependent Ca^2+^ changes in both central- and peripheral nervous system axons ([@bib19]; [@bib11]; [@bib90]; [@bib35]; [@bib93]; [@bib24]). However, when quantifying the specific fraction of block Ca~V~ channels explained only \~35% of the total Ca^2+^ entry during a single AP ([Figure 3](#fig3){ref-type="fig"}). These results are consistent with recent 2-photon Ca^2+^ imaging from the prefrontal cortical pyramidal neuron AIS, showing that \~70% of the \[Ca^2+^\]~i~ transients evoked by a train of three APs remains in the presence of T-type Ca~V~ channel block ([@bib24]). Here, we found that for APs the remaining \~65% of \[Ca^2+^\]~i~ increase is actually TTX-sensitive and this accounted even for \>90% of the subthreshold-induced \[Ca^2+^\]~i~ changes ([Figure 4](#fig4){ref-type="fig"} and [Figure 5](#fig5){ref-type="fig"}). That Ca^2+^ enters through Na~V~ channels builds on landmark studies showing that the initial component of depolarization-induced Ca^2+^ entry in the squid giant axon is tetrodotoxin (TTX)-sensitive ([@bib6]; [@bib64]; [@bib18]). Squid axons even generate rapid spikes in the sole presence of Ca^2+^ ions ([@bib88]). A TTX-sensitive Ca^2+^ current has also been identified in hippocampal neurons ([@bib3]) and more extensively investigated in cardiac myocytes ([@bib1]; [@bib75]; [@bib27]; [@bib43]; [@bib22]). The incomplete selectivity of toxins and blockers for Ca^2+^ channels continued, however, to cast doubt about the precise identity of the TTX-sensitive Ca^2+^ current ([@bib27]; [@bib22]; [@bib82]). Indeed, an alternative explanation for some of the present results is that TTX blocks a Ca~V~ channel subtype. This has been reported at very high concentrations (30 µM) for Ca~V~3.3 ([@bib82]), which is higher than what we used (1 µM). Although we cannot exclude the presence of a TTX-sensitive Ca~V~ channel at the AIS that is not blocked by one of the compounds used in the pharmacological screening ([Figure 3](#fig3){ref-type="fig"}), our optically recorded *I*~Ca~ provides biophysical evidence that the TTX-sensitive Ca^2+^ current follows the same rapid activation time course as the Na^+^ channel pore, incompatible with T-type channel kinetics ([Figure 6](#fig6){ref-type="fig"}). Importantly, in further support that Na~V~ channels give rise to cytoplasmic Ca^2+^ changes, heterologous expression of α- and β-subunits of Na~V~1.2, known to be expressed in the rodent and human AIS ([@bib33]; [@bib47]; [@bib86]), showed that the channel proteins expressed in isolation were sufficient to mediate Ca^2+^ influx ([Figure 7](#fig7){ref-type="fig"}). These results are in support of the findings by Lederer and colleagues showing that heterologous expression of hNa~V~1.5 channel produces depolarization-evoked \[Ca^2+^\]~i~, if expressed with its β subunits ([@bib27]; [@bib37]).

From an evolutionary point of view, some Ca^2+^ permeation of Na~V~ channels is not surprising. Na~V~ channels evolved from the Ca~V~ channel superfamily and share molecular structure both in their pore sequence and intracellular regulatory domains ([@bib92]; [@bib9]). Furthermore, the Born radii for Na^+^ and Ca^2+^ are comparable (1.68 and 1.73 Å, respectively) and Ca^2+^ ions are known to enter the Na~V~ channel pore to block Na^+^ permeation in a concentration-dependent manner ([@bib59]; [@bib5]). Interestingly, single residue mutations in the selectivity filter of Na~V~ channels suffices to increase Ca^2+^ ion permeation ([@bib41]; [@bib66]). Our calculations indicate that the conductivity of the Na~V~ channel for Ca^2+^ is \~0.4% ([Figure 7](#fig7){ref-type="fig"}). If we assume there exists proportionality between permeability and conduction we can apply the equation of permeability \~ conductance/concentration × valency^2^ ([@bib6]; [@bib64]). With our extracellular solutions \[Ca^2+^\]~o~/\[Na^+^\]~o~ being 0.0148 and the valence ratio (Ca^2+^/Na^+^)^2^ being four we can calculate that Na~V~ channels in mammalian axons have a *P*~Ca~/*P*~Na~ ratio of 0.06. Notably, the value is in range of direct recordings for *P*~Ca~/*P*~Na~ in the sciatic nerve and squid axons (0.10 and 0.14, [@bib44]; [@bib64]) as well as recordings from Na~V~1.5 channels revealing *P*~Ca~/*P*~Na~ ratios of \~0.04 ([@bib27]). Such permeability is orders of magnitude lower than *P*~Ca~/*P*~Na~ ratios of acetylcholine receptors or NMDA receptors (1.0 and 17, respectively) ([@bib59]; [@bib48]). An independence of Na^+^ and Ca^2+^ ions, modeled as ohmic conductances, will be a major simplification of the Na~V~ channel under multi-ion conditions. Molecular dynamic studies of Na~V~ channels showed that ionic interactions between Na^+^ and Ca^2+^ at the channel pore are complex ([@bib26]; [@bib17]; [@bib66]). The energy barrier of the selectivity filter strongly favors Na^+^ ions but can be flexible, changing in conformational states and consistent with modest Ca^2+^ permeation ([@bib26]; [@bib17]; [@bib66]). In future experiments it will be interesting to obtain more detailed permeability ratios (*P*~Ca~/*P*~Na~) by recording changes in *E*~rev~ with varying intra- and extracellular concentrations, fitting the data to mathematical solutions such as the electro-diffusion theory of Goldman-Hodgkin-Katz (GHK) extended with surface charge potentials ([@bib59]; [@bib20]), or using Eyring--Läuger theory based on individual ionic rate constants ([@bib58]). Such experiments would in particular be interesting for Na~V~1.6, the main isoform expressed in axonal domains ([@bib60]; [@bib56]).

Although the Ca^2+^ conductivity of the channels is small it achieves near--micromolar Ca^2+^ changes in axons as Na~V~ channels are clustered to very high densities (\~1000 channels µm^--2^) at the AIS and nodes of Ranvier ([@bib68]; [@bib60]; [@bib56]). Consistent with this idea, our imaging experiments showed that also nodes of Ranvier produced subthreshold-activated Ca^2+^ entry ([Figure 1](#fig1){ref-type="fig"} and [Figure 4](#fig4){ref-type="fig"}), suggesting that Na~V~ channel mediated Ca^2+^ entry could play similar roles in these domains. At the AIS, the rapid opening of high densities of Na~V~ channels may further act as a trigger to amplify \[Ca^2+^\]~i~ via the activation of ryanodine receptors, mediating ER store release of Ca^2+^ from the giant saccular organelle, which extends continuously along the AIS of thick-tufted L5 pyramidal neurons ([Figure 2](#fig2){ref-type="fig"}).

The rapid inactivation of Na~V~ channels compared to the slow inactivation of Ca~V~ channels will lead to voltage- and time-dependent changes in the relative contribution of Na~V~ and Ca~V~ channels to \[Ca^2+^\]~i~. In axons, a single AP will mostly lead to Na~V~-mediated Ca^2+^ entry while an increasing number of APs, or longer sustained depolarization, will lead to an accumulation of Ca^2+^ mediated byCa~V~ channel activation. Indeed, Ca^2+^ entry via Ca~V~ channels has been identified as a major contributor to Ca^2+^ entry in sciatic nerve or Purkinje axons during trains of APs or prolonged depolarization for hundreds of milliseconds ([@bib19]; [@bib93]). However, in vivo recordings from L5 pyramidal neurons show that they typically fire sparsely and on average \~1--4 Hz ([@bib28]) and the half-width of axonal APs is about \~300 µs ([@bib55]). In this view, Na~V~-mediated Ca^2+^ entry may be the main source for activity-dependent \[Ca^2+^\]~i~ in the excitable domains of axons under physiological conditions.

What could be the functional role of Na~V~-mediated Ca^2+^ entry in axon initial segments and nodes of Ranvier? One downstream target of submembranous axoplasmic \[Ca^2+^\]~i~ may be regulation of Na~V~ inactivation kinetics via their Ca^2+^/calmodulin domain at their C-terminus as has been demonstrated for multiple Na~V~ subtypes, including Na~V~1.2 and Na~V~1.6 ([@bib76]; [@bib72]; [@bib9]; [@bib87]). Another target of Na~V~-mediated Ca^2+^ could be to open axonal large-conductance BK~Ca~ channels. The BK~Ca~ channel opens with the cooperative action of membrane voltage and \[Ca^2+^\]~i~ ≥10 µM to repolarize APs and shorten their duration ([@bib13]). Across cell types there are considerable variations in the magnitude and time course of BK~Ca~ currents due to differences in nanodomain coupling with Ca~V~ channel isoforms. BK~Ca~ channels are exclusively activated by P/Q-type Ca~V~ channels in cerebellar Purkinje neurons with short AP durations ([@bib89]), but in rat chromaffin cells with wider APs, BK~Ca~ channels are coupled with the Q- and slower activating L-type Ca~V~ channels ([@bib70]). Also in L5 pyramidal neurons BK~Ca~ activation shortens the duration of somatic APs from \~1 ms to \~600 µs ([@bib90]; [@bib16]; [@bib73]). Considering the brief duration of axonal APs in the L5 pyramidal neurons (\~300 µs, [@bib55]) Na~V~ channels may provide both a precisely-timed voltage-dependent activation, via Na^+^ current, as well as a \[Ca^2+^\]~i~ rise within 150 µs ([Figure 9](#fig9){ref-type="fig"}), to rapidly open BK~Ca~ channels and shape axonal AP repolarization. In agreement with this conjecture our data show that T- and L-type Ca~V~ channels are too slow to mediate somatic AP repolarization, leaving open the possibility that a Na~V~-BK~Ca~ channel nanodomain coupling provides the required Ca^2+^ signal. Firm evidence for such interaction would require mutating the selectivity filter of Na~V~ channels to abolish Ca^2+^ but not Na^+^ permeation. Recent two-photon Ca^2+^ uncaging experiments already showed that the \[Ca^2+^\]~i~ rise at the first node of Ranvier in L5 axons opens nodal BK~Ca~ channels to shorten the AP duration and facilitate the generation of high firing rates in the proximal axon ([@bib73]). Further downstream from the initiation site nodal BK~Ca~ channels in Purkinje axons play a role in augmenting the hyperpolarization following APs and facilitate recovery from Na~V~ inactivation to prevent propagation failures ([@bib46]). The dual permeation of axonal Na~V~ channels for Na^+^ and Ca^2+^ ions may thus serve a common function; mediating the rapid electrical upstroke of the AP and via Ca^2+^ signaling activating K^+^ efflux to recover from inactivation and accelerating Na~V~ channel availability for the next AP, representing a fine-tuning specifically to the needs of axonal AP generation and conduction fidelity.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species) or resource   Designation                             Source or reference         Identifiers                                                       Additional information
  ------------------------------------ --------------------------------------- --------------------------- ----------------------------------------------------------------- ------------------------
  Gene (human)                         SCN2A                                   Genscript, USA ([@bib10])                                                                     

  Gene (human)                         SCN1B/SCN2B                             Genscript, USA ([@bib10])                                                                     

  Cell line (Homo-sapiens)             HEK-293T/17                             ATCC                        Cat\#: CRL-11268,\                                                
                                                                                                           RRID:[CVCL_1926](https://scicrunch.org/resolver/CVCL_1926)        

  Commercial assay or kit              GeneJET Plasmid Maxiprep kit            ThermoFisher, USA           Cat\#: K0491                                                      

  Chemical compound, drug              Ryanodine                               Tocris                      Cat\#: 1329                                                       

  Chemical compound, drug              Heparin                                 Tocris                      Cat\#: 2812                                                       

  Chemical compound, drug              TTA-P2                                  Alomone                     Cat\#: T-155                                                      

  Chemical compound, drug              Isradipine                              Tocris                      Cat\#: 2004                                                       

  Chemical compound, drug              Nickel                                  Sigma                       Cat\#: N6136                                                      

  Chemical compound, drug              Nimodipine                              Tocris                      Cat\#: 0600/100                                                   

  Chemical compound, drug              SNX-482                                 Tocris                      Cat\#: 2945                                                       

  Chemical compound, drug              ω-conotoxin MVIIC                       Tocris                      Cat\#: 1084                                                       

  Chemical compound, drug              KB-R7943                                Tocris                      Cat\#: 1244                                                       

  Chemical compound, drug              SN-6                                    Tocris                      Cat\#: 2184                                                       

  Chemical compound, drug              TTX                                     Tocris                      Cat\#: 1069                                                       

  Chemical compound, drug              QX-314                                  Alomone                     Cat\#: Q-150                                                      

  Chemical compound, drug              EGTA                                    Sigma                       Cat\#: E0396 (low extracellular Ca^2+^),\                         
                                                                                                           Cat\#: 3777 (HEK-cell experiments)                                

  Chemical compound, drug              CNQX                                    HelloBio                    Cat\#: HB0205                                                     

  Chemical compound, drug              D-AP5                                   HelloBio                    Cat\#: 0225                                                       

  Chemical compound, drug              ZD-7288                                 Tocris                      Cat\#: 1000                                                       

  Chemical compound, drug              XE991                                   Tocris                      Cat\#: 2000                                                       

  Chemical compound, drug              Gabazine                                Sigma                       Cat\#: S106                                                       

  Chemical compound, drug              OGB-5N                                  Invitrogen                  Cat\#: O6812                                                      

  Chemical compound, drug              OGB-1                                   Invitrogen                  Cat\#: O6806                                                      

  Chemical compound, drug              Bis-Fura2                               Biotium                     Cat\#: 50045                                                      Discontinued

  Chemical compound, drug              SBFI                                    Invitrogen                  Cat\#: 10033152                                                   

  Chemical compound, drug              JPW3028                                 Potentiometric Probes       JPW3028                                                           

  Antibody                             anti-synaptopodin (Rabbit polyclonal)   Sigma                       Cat\#: S9442,\                                                    (1:500)
                                                                                                           RRID:[AB261570](https://scicrunch.org/resolver/AB261570)          

  Antibody                             Anti-ankyrinG (mouse monoclonal)        Neuromab                    Cat\#: 75--146,\                                                  (1:100)
                                                                                                           RRID:[AB_10673030](https://scicrunch.org/resolver/AB_10673030))   

  Antibody                             Anti-βIV spectrin (mouse monoclonal)    Neuromab                    Cat\#: 75--377,\                                                  (1:250)
                                                                                                           RRID:[AB_2315818](https://scicrunch.org/resolver/AB_2315818))     

  Other                                streptavidin Alexa-488 conjugate        Invitrogen                  Cat\#: S32354,\                                                   (1:500)
                                                                                                           RRID:[AB_2315383](https://scicrunch.org/resolver/AB_2315383)      

  Software, algorithm                  Neuroplex                               RedShirt Imaging            RRID:[SCR_016193](https://scicrunch.org/resolver/SCR_016193)      

  Software, algorithm                  Axograph                                Axograph                    RRID:[SCR_014284](https://scicrunch.org/resolver/SCR_014284)      Version 1.7.0

  Software, algorithm                  GraphPad Prism                          GraphPad Prism              RRID:[SCR_002798](https://scicrunch.org/resolver/SCR_002798)      Version 8.4.2

  Software, algorithm                  FIJI                                    [@bib77]                    RRID:[SCR_002285](https://scicrunch.org/resolver/SCR_002285)      

  Software, algorithm                  μManager                                [@bib30]                    RRID:[SCR_016865](https://scicrunch.org/resolver/SCR_016865)      

  Software, algorithm                  NEURON                                  [@bib45]                    RRID:[SCR_005393](https://scicrunch.org/resolver/SCR_005393)      

  Software, algorithm                  Maxchelator                             [@bib15]                    RRID:[SCR_000459](https://scicrunch.org/resolver/SCR_000459)      

  Software, algorithm                  FrameSplitter                           [@bib8]                     <https://github.com/Kolelab/Image-analysis>                       
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Ethical approval {#s4-1}
----------------

All animal experiments were performed in compliance with the European Communities Council Directive 2010/63/EU effective from 1 January 2013. They were evaluated and approved by the national CCD authority (license AVD8010020172426) and by the KNAW animal welfare and ethical guidelines and protocols (DEC NIN 14.49, DEC NIN 12.13, IvD NIN 17.21.01 and 17.21.03). Written informed consent was obtained from patients and all procedures on human tissue were performed with the approval of the Medical Ethical Committee of the Amsterdam UMC, location VuMC and in accordance with Dutch license procedures and the Declaration of Helsinki. All data were anonymized.

Tissue collection {#s4-2}
-----------------

Young-adult male Wistar rats (RjHan:WI) were used at an age between P21 and P35 (Charles River Laboratories and Janvier labs). Animals were deeply anaesthetized by 3% isoflurane inhalation, decapitated and 300 µm parasagittal slices containing the primary somatosensory cortex were cut with a Vibratome (1200S, Leica Microsystems B.V.) within ice-cold artificial cerebrospinal fluid (ACSF) of the following composition (in mM): 125 NaCl, 3 KCl, 25 glucose, 25 NaHCO~3~, 1.25 Na~2~H~2~PO~4~, 1 CaCl~2~, 6 MgCl~2~, saturated with 95% O~2~ and 5% CO~2~ (pH 7.4). Following a recovery period at 35°C for 35--45 min slices were stored at room temperature in the ACSF. Human slices were obtained from non-pathological cortex removed for the surgical treatment of deeper brain structures for mesial temporal lobe epilepsy. After resection, a block of the temporal lobe was placed within 30 s in ice-cold artificial cerebrospinal fluid (ACSF) slicing solution which contained in (mM): 110 choline chloride, 26 NaHCO~3~, 10 D-glucose, 11.6 sodium ascorbate, 7 MgCl~2~, 3.1 sodium pyruvate, 2.5 KCl, 1.25 NaH~2~PO~4~, and 0.5 CaCl~2~ (300 mOsm) and transported to the laboratory, as described in detail previously ([@bib85]). Transition time between resection of the tissue and preparation of the slices was \<15 min. Neocortical slices (\~350 µm thickness) were cut in an ice-cold slicing solution, stored for 30 min at 34°C, and afterwards switched to room temperature in standard ACSF. Slices were subsequently transported (\<15 min) towards the NIN (KNAW) in continuously carbogenated ACSF.

Cell lines {#s4-3}
----------

Human embryonic kidney 293 cells (HEK 293T/17 cell line, CRL-11268 obtained from ATCC) were cultured in growth medium consisting of equal parts of Dulbecco's modified Eagle's medium (DMEM) (DMEM Glutamax, Gibco, Thermo Fisher Scientific) and Ham's F10 nutrient mix (Gibco, Thermo Fisher Scientific), supplemented with 10% fetal calf serum (FCS) and 1% penicillin--streptomycin. Cells were split twice a week by trypsinization and grown at 37°C with a humidified atmosphere containing 5% CO~2~. STR profiling confirmed a 100% match with the HEK 293T cellline (ATCC). Human *SCN2A* (D-splice variant), encoding for the alpha subunit of the Na~V~1.2 channel was cloned in pcDNA3.1-IRES-GFP, and *SCN1B/SCN2B*, encoding for beta subunits 1 and 2, was cloned into pcDNA3.1. These vectors were described previously ([@bib10]) and obtained from Genscript (Genscript, USA). The constructs were amplified in Stbl3 bacteria (Genscript, USA) and were purified using the GeneJET Plasmid Maxiprep kit (ThermoFisher, USA) according to the manufacturer's protocols. The plasmids were transiently transfected into 70% confluent HEK-293 cells plated in 12-well plates. Per well, the transfection cocktail contained 500 ng pcDNA3.1-SCN2A-IRES-GFP, 290 ng pcDNA3.1-SCN1B- IRES-SCN2B and 5 μL of polyethylenimine (PEI) diluted in 100 μL 1% saline, incubated for 20 min at room temperature before addition to the culture medium. Cells were incubated with 100 μL of transfection cocktail in 1 mL of culture medium for 24 hr at 37°C in a humidified atmosphere containing 5% CO~2~. Cells were trypsinised and used for electrophysiological recording typically 48 hr after transfection.

Electrophysiological recording from neurons {#s4-4}
-------------------------------------------

For patch-clamp recording, slices were transferred to a customized upright microscope (BX51WI, Olympus Nederland BV, or LNscope, Luigs and Neumann, Ratingen, Germany). The transmitted light path consisted of a custom made 850 nm Light Emitting Diode (LED) light source (LZ1-10R602, LED Engin, CA), collimated using an aspheric condenser lens (ACL50832U-B, Thorlabs, Germany) and adapted to the microscope lamp port using a custom 3D printed adapter and passed through an oblique or Dodt illumination condenser (WI-OBCD, Olympus). The top 50 µm of the slice surface was visualized using an optical pathway consisting of a 60× water immersion objective (N.A. 1.0, LUMPLFLN60XW, Olympus or N.A. 1.1, LUMPLFLN60XW, Olympus), 2× intermediate zoom attachment (U-ECA, Olympus), camera splitter (U-TRU, Olympus) with inbuilt 180 mm tube lens on the back port and a 0.63× demagnifier (U-TV0.63XC, Olympus) projected the final image onto a high resolution CCD camera (CoolSNAP-EZ, Photometrics), which was operated using μManager ([@bib30]). Based on the bright-field image large L5 neurons with an intact axon parallel and close to the surface were targeted for recording. Current-clamp recordings were made with Dagan BVC-700A amplifiers (Dagan Corporation, MN, USA) or AxoClamp 900A (Molecular Devices Limited, UK). An Axopatch 200B (Molecular Devices) was used for voltage-clamp and AP-clamp experiments. The microscope bath was perfused with oxygenated (95% O~2~, 5% CO~2~) ACSF consisting of (in mM): 125 NaCl, 3 KCl, 25 glucose, 25 NaHCO~3~, 1.25 Na~2~H~2~PO~4~, 2 CaCl~2~, and 1 MgCl~2~. Patch pipettes were pulled from borosilicate glass (Harvard Apparatus, Edenbridge, Kent, UK) pulled to an open tip of 3--6 MΩ resistance. For all current-clamp, subthreshold voltage-clamp ramp and AP-clamp recordings the intracellular solution contained (in mM): 130 K-Gluconate, 10 KCl, 4 Mg-ATP, 0.3 Na~2~-GTP, 10 HEPES and 10 Na~2~-phosphocreatine (pH 7.25 adjusted with KOH, 280 mOsmol kg^−1^). The liquid junction potential difference of --13.5 mV was corrected in all recordings. For morphological reconstruction, 5 mg ml^−1^ biocytin was routinely added. Voltage recordings were analogue low-pass filtered at 10 kHz (Bessel) and digitally sampled at 100 kHz using A-D converter (ITC-18, HEKA Elektronik Dr. Schulze GmbH, Germany) and data acquisition software Axograph X (v.1.5.4, Axograph Scientific, NSW, Australia). Bridge-balance and capacitances were fully compensated based on small current injections leading to minimal voltage errors. The recording temperature was 33 ± 1°C. Only cells with a stable bridge-balance (\<25 MΩ), resting membrane potential and AP shape throughout the recording session were included in the analysis.

For voltage-clamp recordings of *I*~Na~ and *I*~Ca~ ([Figure 5](#fig5){ref-type="fig"}) the bath was perfused with oxygenated (95% O~2~, 5% CO~2~) extracellular recording solution consisting of (in mM): 100 NaCl, 3 KCl, 25 glucose, 25 NaHCO~3~, 1.25 Na~2~H~2~PO~4~, 2 CaCl~2~, 1 MgCl~2~, 5 4-AP, 20 TEA-Cl, 0.02 CNQX, 0.05 D-AP5, 0.02 ZD-7288, 0.01 XE991 and 0.003 Gabazine (SR-95531). The intracellular solution contained (in mM): 130 CsCl, 10 TEA-Cl, 10 HEPES, 4 Mg-ATP, 5 Na~2~-phosphocreatine and 0.3 Na~2~-GTP (pH 7.25 adjusted with CsOH, 280 mOsmol kg^−1^). A liquid junction potential of --5.6 mV was applied to the recordings. Series resistance was routinely compensated to \>75% and the linear leak and capacitance off-line subtracted using a P/9 protocol with 10-fold scaled pulses. Current recordings were analogue low-pass filtered at 10 kHz (Bessel) and digitally sampled at 100 kHz using A-D converter (ITC-18, HEKA Elektronik Dr. Schulze GmbH, Germany) and data acquisition software Axograph X (v.1.5.4, Axograph Scientific, NSW, Australia). To improve voltage-clamp of the large and rapid Na^+^ currents the recordings were made at room temperature (\~20°C).

Electrophysiological recordings from HEK-293 cells {#s4-5}
--------------------------------------------------

For recordings from HEK-293 cells they were transferred to a recording chamber which was continuously perfused with extracellular solution, containing (in mM): 135 NaCl, 4.5 KCl, 2 CaCl~2~, 1 MgCl, 10 HEPES and 11 Glucose. The intracellular solution contained (in mM): 110 CsF, 10 NaCl, 20 EGTA and 10 HEPES. In the OGB-1 experiments, we added 100 µM OGB-1, EGTA was omitted and CsF raised to 120 mM instead of 110 mM. The liquid junction potential difference of --10 mV was corrected for. Whole-cell patch-clamp recordings were made \~48 hr after transfection. Cells were recorded at room temperature (\~20°C) and continuously perfused with extracellular solution at a flow rate of 1.5 mL∙min^--1^. Patch pipettes were pulled to a resistance of 2--3 MΩ. Round, isolated cells with a diameter \>10 μm, a smooth cell surface and a moderate EGFP fluorescent signal were selected for recordings ([Figure 7a](#fig7){ref-type="fig"}). HEK-293 cells had an average capacitance of 9.19 ± 0.70 pF (*n* = 16). The holding potential was --70 mV and voltage dependence of activation of Na~V~1.2 was determined by an activating protocol consisting of a hyperpolarizing pulse to --130 mV (20 ms) followed by step pulses from --80 mV to +50 mV with increments of 10 mV for 20 ms. Voltage dependence of inactivation was assessed with voltage pulses from --130 mV to --30 mV with increments of 10 mV for 100 ms duration, followed by a depolarizing pulse to --20 mV for 20 ms. A P/5 leak subtraction protocol (10-fold scaling) was used to subtract remaining capacitive and leak currents. Series resistance was not compensated.

Blockers and toxins {#s4-6}
-------------------

EGTA and blockers were added to the appropriate concentration to the ACSF and perfused. The extracellular Ca^2+^ (\[Ca^2+^\]~o~) was lowered by bath application of 2.5 mM EGTA and using the online maxchelator tool (<https://somapp.ucdmc.ucdavis.edu/pharmacology/bers/maxchelator/CaMgATPEGTA-TS.htm>; [@bib15]) we calculated the remaining \[Ca^2+^\]~o~ to be 437 nM, based on a recording temperature of 35°C, a pH of 7.4 and an ionic strength of 0.15 M of the free ions in our solution. To limit hyperexcitability in the presence of EGTA, we added synaptic blockers to the ACSF (20 µM CNXQ and 50 µM D-AP5) and kept the a-EPSP voltage peak amplitude constant by reducing the amplitude of the current injections in both control and EGTA measurements ([Figure 2](#fig2){ref-type="fig"}). To prevent precipitation of Ni^2+^ we used phosphate-free extracellular solutions containing (in mM): 126.25 NaCl, 3 KCl, 25 glucose, 25 NaHCO~3~, 2 CaCl~2~, 1 MgCl~2~ and 0.1 Ni^2+^. A \> 10% increase in fluorescence baseline was observed in some experiments (3 out of 8 recordings), which were subsequently excluded. Two blockers (SNX-478 and ω-conotoxin MVIIC) were not perfused but were locally puffed using a Picospritzer III (Intracel) for 3 s ending 0.5 s before imaging to avoid vibration artifacts. Bovine serum albumin (0.1 mg/ml) was added to the rACSF before ω-conotoxin MVIIC was introduced to minimize non-specific binding of the drug.

Ca^2+^ and Na^+^ imaging {#s4-7}
------------------------

To optically record \[Ca^2+^\]~i~ and \[Na^+^\]~i~ in axons, membrane impermeable Ca^2+^ and/or Na^+^ indicators were added to intracellular solutions. For Ca^2+^ we used OGB-1 (100 µM), OGB-5N (1 mM) or bis-Fura-2 (200 µM) and for Na^+^ imaging we used sodium-binding benzofuran isophthalate (SBFI, 1--1.5 mM). Patch pipettes were first filled with dye-free solution for half of the tapered part of the pipette tip, then backfilled with the dye-containing solution. Fluorescence intensity at the AIS was monitored during dye loading and imaging started only when the indicators were fully equilibrated (typically after 0.5--1 hr). Optical recordings of Ca^2+^ or Na^+^ dye fluorescence changes were obtained with wide-field epifluorescence microscopy. Fluorescence was collected by the same 60× water immersion objective, passed through the microscope tube lens (U-TR30IR, Olympus) and projected onto a rapid data-acquisition camera with relatively low spatial resolution (80 × 80 pixels) but high dynamic range (14 bits) and low read noise (NeuroCCD-SM, RedShirtImaging LLC, Decatur, GA) via a 0.1× or 0.35× demagnifier. The CCD frame corresponded to an area of approximately 320 or 91 µm^2^ in the object plane with each individual pixel receiving light from an area of ∼4 × 4 or 1.1 × 1.1 µm^2^, respectively. High-speed recordings (20 kHz) were always performed with the 0.35× demagnifier and with 3 × 3 binning of pixels on the chip, the ultimate pixel sizes in these recordings were ∼3.4 × 3.4 µm^2^. The two recordings from human cells were performed under a 100× NA 1.1 Nikon objective (MRL07920) in combination with a 0.1× demagnifier, resulting in a pixel size of ∼2.4 × 2.4 µm^2^ (see [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}).

The epifluorescence light path consisted of an excitation LED light source, which was collimated using an aspheric lens (ACL5040U-A, Thorlabs, Germany) and the appropriate excitation filter, dichroic mirror and emission filter. For OGB-1 and OGB-5N excitation a 470 nm LED was used (SP-01-B4, Luxeon Star LEDs, Canada), the excitation light was filtered with 475/30 nm (475 nm center wavelength, 30 nm wide) excitation filter, reflected to the preparation by a dichroic mirror with a central wavelength of 500 nm and the fluorescence light was passed through a 520 nm barrier filter (U-MWB2 cube, Olympus). For SBFI excitation, LED light (365 nm LED, LZ1-10UV00, Ledengin, USA) was filtered by 357/44 nm filter (FF01-357/44-25, Semrock), a dichroic mirror with edge at 415 nm (Di03-R405-t1−25 × 36, Semrock) reflected excitation light to the sample and the emission light was then passed through a long-pass colored glass filter with the edge at 400 nm (FGL400, Thorlabs). For combined Na^+^ and Ca^2+^ imaging ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), the light from the 365 and 470 LEDs was combined by a dichroic mirror with edge at 458 nm (FF458-Di02, Semrock) and the filter set switched between trials. Light was directed through a fluorescence illuminator (BX-RFA, Olympus) equipped with a rectangular field stop providing an open area of 150 × 250 µm to reduce phototoxicity (U-RFSS, Olympus). The cell body was positioned just outside the field stop and the axon in the middle parallel to the long side (see e.g. [Figure 1](#fig1){ref-type="fig"}).

The critical benefit of epifluorescence measurements over two-photon imaging is increased light collection (\~90% quantum efficiency, low-read noise of the CCD camera) enabling a high sensitivity and temporal fidelity. We optimized all imaging parameters to obtain maximal signal to noise ratio, which allowed us to image at the maximum acquisition rate of 20 kHz. In addition to the light collection optimization and selective targeting of superficial neurons, multiple trials were averaged to improve signal-to-noise ratio (typically 20--40). Fluorescence signals were temporally aligned to the electrophysiological voltage or current signals. For optical recording of *I*~Ca~, which requires the transformation of ΔF/F into the first time derivative, Ca^2+^ binding to the indicator must be proportional to \[Ca^2+^\]~i~ and the endogenous buffering capacity to be low. Based on the submillisecond equilibration time of OGB-5N and imaging at the maximally possible frame rate of 20 kHz it was recently shown that in CA1 hippocampal neurons these conditions are met and optically recorded *I*~Ca~ tracks electrically recorded *I*~Ca~, enabling the identification of Ca~V~ channel subtypes in dendrites ([@bib50]). Considering the low buffering capacities of endogenous buffers in the axon (κ~s~ ≈ 20) ([@bib51]; [@bib29]), we employed this technique in the AIS. Ca^2+^ imaging in HEK-293 cells was performed with 0.1 mM OGB1 added to the HEK-293 cell intracellular solution (from which EGTA was omitted). The fluorescence was recorded during a 200 Hz 1 s train of depolarizing pulses from --120 to --30 or --20 mV (corrected for liquid junction potential).

Voltage imaging {#s4-8}
---------------

Voltage imaging in neurons was performed as reported previously ([@bib40]). Neurons were filled with intracellular solution containing JPW3028 (0.8 mM) for typically 1 hr at room temperature, after which the patch pipette was retracted and the dye was left to diffuse into the lipid membranes for 1--4 hr. Subsequently the bath temperature was increased to 35°C and the cell was re-patched with normal intracellular solution. A 530 nm LED (SP-05-G4, Luxeon Star LEDs, Canada) was used for excitation of the dye. The excitation light was filtered with a 530/20 nm filter (BP510-550, Olympus), reflected to the sample by a dicroic mirror with a center wavelength of 570 nm (DM570, Olympus) and the emission light filtered by a 590 longpass filter (BA590, Olumpys). Data were collected at 20 kHz and low-pass filtered by a binomial filter (one pass) and averaged over 20--30 trials. Voltage imaging in HEK-293 cells was performed identically, with the only exception being that the experiments were performed at 20°C and the dye diffused equally in the small round cells, so imaging experiments were initiated 20 min after obtaining whole-cell configuration. The cells were maintained at --75 mV holding potential and the fluorescence of JPW3028 recorded at 1 kHz. The voltage command consisted of 100 ms steps of 50 mV increasing steps with a maximal step of +250 mV relative to holding potential. The average ΔF/F per voltage step was defined as the first 20 frames of each bleach corrected and normalized voltage step.

Imaging data analysis {#s4-9}
---------------------

Imaging data analysis was performed using Neuroplex (Redshirt imaging), Axograph and Excel. Fluorescence signals were always background-subtracted. To correct for bleach effects, every 5^th^ trial was recorded without current injection. A first order exponential was fitted to the average of the bleach trials and normalized to the peak. The average of the signal trials was divided by this trace to correct for bleach decay. Values for each ROI were defined as a fractional fluorescence change (ΔF/F~baseline~), where F~baseline~ is the raw intensity average of 10 frames before the signal (subthreshold or AP) was initiated. Pixels were color coded with 'physics' color scheme from FIJI image processing software (NIH, USA) ([@bib77]). For both OGB-1 and OGB-5N, we recorded the fluorescence in response to subthreshold stimuli, single APs and multiple APs. The ΔF/F response to subthreshold stimuli and a single AP was always below dye saturation. For OGB-1, we recorded trains of APs and observed that a single AP was 25 ± 2.7% of dye saturation (*n* = 8) and for OGN-5N, we observed a linear increase from 1 to 3 APs (*n* = 3), indicating that the fluorescence of a single AP was far from dye saturation.

Optical current measurements {#s4-10}
----------------------------

To compare kinetics between electrically and optically recorded currents, electrical currents were first downsampled to 20 kHz (optical acquisition rate). The optical trace was differentiated and then inverted (to mimic *I*~Na~, which is conventionally depicted as a negative, inward current). All current traces were then filtered with a 3-window binomial filter of 50--150 iterations (generally 100). The traces were baselined to the current before the onset of the fast current and normalized to the peak of the current. Because the *I*~Ca_opt~ traces were too noisy to be fitted with a single exponential fit, conventionally used to obtain activation rise time, we used a Boltzmann sigmoid function to obtain the slopes of the traces.$$y = bottom + \frac{\left( {top - bottom} \right)}{1 + e^{(\frac{x - x_{0}}{k})}}$$

We fitted all traces using Axograph and the slope values (*k*) were used to compare activation kinetics. Although the *I*~Na~ peak amplitude recorded at the soma highly varied between neurons (--36.61 ± 6.53 nA), the slope was nearly constant (207 ± 0.007 µs, *n* = 17).

Ratiometric imaging {#s4-11}
-------------------

To estimate the absolute \[Na^+^\]~i~ and \[Ca^2+^\]~i~ in response to a single AP, we used a ratiometric imaging approach. Patch pipettes were front filled with clear intracellular solution and back-filled with intracellular solution containing 1.5 mM SBFI (Invitrogen) or 200 µM bis-Fura-2 hexapotassium salt (bF2, Biotium). Fluorescent emission of ratiometric indicators depends on the ionic concentration and the excitation wavelength where an increase in \[Ca^2+^\]~i~ produces an increase in bF2 fluorescence with the wavelength of 340 nm but a decrease with 385 nm. On the other hand, with SBFI an increase in \[Na^+^\]~i~ decreases SBFI fluorescence at 340 nm but does not alter at 385 nm excitation wavelength. Using the ratio (*R*) corrects for differences in cytosolic volume or dye concentration differences along imaged compartments ([@bib57]). The sources of excitation light were two LEDs (Thorlabs) with peaks at 340 nm and 385 nm, fitted with band pass excitation filters at 340/22 and 387/11 nm (FF01-340/22-25 and FF01-387/11-25, Semrock) and combined by a dichroic mirror with a central wavelength of 376 nm (FF376-Di01−25 × 36, Semrock). The excitation light was reflected to the sample by a dichroic mirror with a central wavelength at 405 nm (Di01-R405−25 × 36, Semrock) and passed through the objective to the sample. The fluorescent emission signals were passed through a 420 long pass filter (Thorlabs). Ratiometric imaging was performed by alternatingly triggering each LED at the frame rate of the camera, as described previously ([@bib65]). This was achieved by combining custom designed Arduino/Parallax machines with Cyclops LED drivers. These hardware solutions allowed us to digitally control the voltage driving the LED, thus having maximum control over excitation light intensity. Fluorescence emission signals originating from each LED were separated with custom written software (FrameSplitter.txt, [@bib8]). The camera operated at 0.5--1.0 kHz, resulting in a ratiometric frame rate of 0.25--0.5 kHz. Per experiment the fluorescent signals were averaged for 40 to 120 trials. The ratio R was defined as F~1~/F~2~, where F~1~ and F~2~ are the background-subtracted fluorescence intensities at excitation with 340 nm and 385 nm, respectively.

Calibration of ratiometric imaging {#s4-12}
----------------------------------

In order to scale ratiometric bF2 signals to absolute changes in Ca^2+^ concentration, we used the standard equation for ratiometric measurements (equation 1 in [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}; [@bib36]), which depends on K~D~, the dissociation constant, R~min~ and R~max~, the ratio in zero and dye-saturating Ca^2+^, respectively and the scaling factor (S~f2~/S~b2~), defined as the fluorescence intensity at excitation with 385 nm of zero Ca^2+^ divided by saturating Ca^2+^. These values were determined in an ex situ calibration, by measuring the ratiometric signal of solutions containing 0 Ca^2+^ and a high \[Ca^2+^\] ([Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}). The solutions closely mimicked intracellular solutions and contained (in mM): 110 K-gluconate, 4.4 or 21 KCl, 0 or 10 CaCl~2,~ 3.8 or 5.36 MgCl~2~, 10 HEPES, 4 Mg-ATP, 0.3 Na~2~-GTP, 10 Na~2~-phosphocreatine, 10 EGTA, and 0.2 bF2. The final free \[Ca^2+^\] depends on interaction between Ca^2+^, Mg^2+^ and EGTA and was calculated using the maxchelator tool ([@bib15]).

\[Ca^2+^\]~min~ was 0 and \[Ca^2+^\]~max~ was 4.39 µM. We repeated the calibration experiment three times. In our experimental setting, the K~D~ of bF2 was 507.3 ± 5.7 nM, which matches with the reported value of 525 nM in the presence of Mg^2+^ (Molecular Probes Handbook, Thermofischer). We then performed ratiometric imaging in the AIS in response to a single AP. ∆R/R was calculated by dividing every ratio by the average of the baseline ratio before the onset of the AP (similar to the conventional ∆F/F). We used the K~D~ as determined from our calibration experiments. The R~min~ was scaled to be \~95% of R~baseline~ to result in resting \[Ca^2+^\]~i~ of 50 nM and R~max~ as established in the calibration experiments. If the LED intensity of the cellular recording was different from the calibration intensity used during the calibration experiments, the R~max~ was corrected linearly, assuming that R~min~/R~max~ was constant. These experiments showed that after a single AP, \[Ca^2+^\]~free~ in the AIS rises with 55.6 ± 12.6 nM (see [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}).

Because R~min~ and R~max~ were not measured in situ we verified the Δ\[Ca^2+^\]~free~ with an alternative analysis that is independent of the exact values for K~D~, R~min~ and R~max~ (equation 2 in [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}; [@bib57]). In this approach, changes in fluorescence ratio ΔR/R~0~ (%) are plotted versus \[Ca^2+^\]~free~, showing a nearly linear increase in ΔR/R~0~ (%) for low \[Ca^2+^\]~free~ (see [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}). A linear fit to the region of \[Ca^2+^\]~i~ between 0 and 193 nM indicated that a 1% increase in ΔR/R~bF2~ corresponded to a Δ\[Ca^2+^\]~i~ of \~10.4 nM (*R*^2^ = 0.99, six concentrations, *n* = 3 repetitions). We measured an AP-evoked Δ\[Ca^2+^\]~free~ of 52.5 ± 12.2 nM ([Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}), in good support of the standard Ca^2+^ measurement approach. We analyzed the ratiometric SBFI data only using this second approach, which is standard for SBFI measurements ([@bib57]). The two base calibration solutions contained (in mM): 130 K-Gluconate or Na-Gluconate, 10 KCl of NaCl, 0.3 Tris~2~-GTP or Na~2~-GTP, 10 HEPES, 4 Mg^2+^ATP, 10 Tris~2~-phospocreatine or Na~2~-phospocreatine, and 1.5 SBFI, pH 7.25 adjusted with Tris base. These two base solutions provided a range of 0--160.6 mM \[Na^+^\]. When normalized to the ratio obtained in Na^+^-free solution (*R*~0~), a 1% increase in Δ*R*/*R*~SBFI~ corresponded to a Δ\[Na^+^\]~i~ of 0.35 mM for Δ\[Na^+^\]~i~ between 0 and 48 mM (*R*^2^ = 0.98; eight concentrations, *n* = 3 repetitions, [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}). An AP evoked a Δ\[Na^+^\]~i~ of 1.49 ± 0.2 mM ([Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}).

Immunofluorescence staining {#s4-13}
---------------------------

Following imaging experiments, the slices were fixed using 4% PFA in 0.1 M phosphate-buffered saline (PBS), pH 7.4 for 20 min and stored in 0.1 M PBS, pH 7.4 at 4°C. For triple immunohistological labeling the slices were washed three times in PBS and then incubated in a blocking solution (10% normal goat serum, 0.5% Triton X-100 in PBS) at room temperature for two hours, followed by 24 hr incubation at room temperature in the blocking solution containing primary antibodies: streptavidin Alexa-488 conjugate (1:500; Invitrogen), primary antibody for giant saccular organelle Synaptopodin (rabbit; 1:500; Sigma-Aldrich Chemie) and antibody for AIS marker: Ankyrin G (mouse; 1:100; Neuromab) or ßIV-spectrin (mouse; 1:250; Neuromab, see also Key Resources Table). The slices were 3x washed in 0.1 M PBS and then incubated with secondary antibodies: Alexa-555 goat anti rabbit IgG (1:500; Invitrogen) and Alexa 633 goat anti mouse IgG (1:500; Invitrogen). Subsequently, the slices were 3x washed in 0.1 M PBS and mounted with Vectashield mounting medium with 4,6-diamidino-2-phenylindole (DAPI; Vector Laboratories). Images (bit depth, 8) were collected as described previously ([@bib39]). To align confocal images and the Ca^2+^ fluorescence images of the RedShirt CCD camera ([Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}) we used the original calibrated images of the two systems. The maximum Ca^2+^ fluorescence image was calibrated within the original optical path. We overlaid the maximum Ca^2+^ fluorescence image of the RedShirt camera and the maximum projection of the streptavidin image of the neuron morphology from confocal microscopy within ImageJ and applied only a rotation translation to visually match the two images based on the AP-evoked Ca^2+^ signals spreading into dendrites and axons.

Model simulations with single compartment {#s4-14}
-----------------------------------------

All model simulations were performed with NEURON (v.7.5) ([@bib45]). A single compartment was created with length and diameter dimensions of 10 µm and *nseg* = 10, with specific membrane capacitance of 1.0 µF cm^--2^, specific membrane resistance of 25 kΩ cm^2^ and specific axial resistivity of 150 Ω cm. The resting membrane potential set to --77 mV using e_pass. Conductance models for Ca^2+^ were based on the high-voltage activated (CaH) and a T-type Ca~V~ channel model (CaT) obtained from ModelDB (<https://senselab.med.yale.edu/ModelDB/>) ([@bib61]). Ca^2+^ conductivity of Na~V~ channels was modeled by including a standard ohmic Ca^2+^ ion mechanism with a reversal potential (*eca*) of +140 mV into a mathematical 8-state Na^+^ conductance model, computing simultaneously voltage- and time-dependence of the Ca^2+^ current *I*~Ca(Na)~ and *I*~Na~ based on experimentally constrained rate constants of somatodendritic and axonal *I*~Na~ ([@bib78]). The kinetics of the voltage-gated conductance models was examined by fitting the current rise times with an exponential function for a --35 mV command potential, resampling the simulated traces to 20 kHz. The results showed that the *I*~Na~ in the model activated with 240 µs and *I*~Ca(Na)~ (0.5% conductivity ratio) with 280 µs. In comparison, *I*~CaT~ activated with 4.88 ms and *I*~CaH~ with 6.51 ms. These time constants are well in range of the experimentally determined values for the TTX- and Ni^2+^-sensitive components recorded at the soma ([Figure 5](#fig5){ref-type="fig"}). For [Figure 8---figure supplement 1](#fig8s1){ref-type="fig"} we used an AP recorded from the L5 pyramidal neuron AIS at 100 kHz (threshold-to-peak, 94 mV; half-width duration of 285 µs \[[@bib38]\] as the command potential in VectorPlay linked to the SEClamp function in NEURON (with *R*~s~ being infinitely small). Single compartmental models were run at *dt* of 10 µs at a nominal temperature of 33°C.

Model simulations with a multicompartmental model {#s4-15}
-------------------------------------------------

Conductance-based multi-compartmental simulations were performed with an anatomically realistic reconstructed rat L5 pyramidal neuron (NeuroMorpho.Org ID: NMO_75667, Neuron Name 2014-04-01_1). The morphology was acquired with a confocal microscope at 2048 × 2048 pixels (1.0 µm *z*-steps, Leica SP8) using a 40× oil immersion objective (NA 1.3) scanning both the biocytin-streptavidin fluorescence and the ßIV-spectrin fluorescence. Uncompressed image stacks (\~20 GB) were imported and reconstructed into Neurolucida (v.10, MBF Bioscience Inc, Germany), compartmentalized for the AIS and nodes as described previously ([@bib39]) and imported with the 3D import tool in NEURON ([@bib21]). Multicompartmental simulations were performed to estimate the detailed ionic accumulation, concentration and diffusion in the proximal sites of the axon and match our experimental recordings as close as possible. Ca^2+^ diffusion, buffering and pump (cdp) mechanisms were implemented based on the algorithms described in the NEURON book (Chapter 9, example 9.8 in [@bib21]) and on a previously published Ca^2+^ model ([@bib31]) (available at ModelDB, accession number 125745, <https://senselab.med.yale.edu/ModelDB/>). We implemented cdp.mod ([@bib31]) with the following alterations: we removed all SERCA related parameters, updated some starting values to our experimental conditions and extended the models to report not only \[Ca^2+^\]~i~, but also to simulate the Ca^2+^ indicator response ΔF/F, using the equation:$$F = \frac{\left\lbrack dye \right\rbrack_{free} + c*\left\lbrack {Ca}^{2 +} + buffer \right\rbrack}{\left\lbrack dye \right\rbrack_{total}}$$

With *c* being a constant to scale simulated ΔF/F. Because the equation was used to match the simulation to experimental data with regard to the temporal dynamics of Ca^2+^ extrusion, the absolute amplitude of ΔF/F was not used and *c* was set to a nominal value of 6. The different Ca^2+^ indicators used experimentally were implemented by adjusting the concentration of the exogenous buffer, and its known or measured K~D~. Static Ca^2+^ buffering properties of endogenous organelles (κ~s~) were simulated with a TBufs of 100--400 µM and KDs of 10 µM, to mimic a κ~s~ of 10--40 ([@bib51]; [@bib29]).

To constrain the peak Na^+^ conductance densities ($\overset{-}{g}$~Na~) we injected a 3 ms square current pulse in the somatic compartment and iteratively adjusted $\overset{-}{g}$~Na~ and $\overset{-}{g}$~K~. We varied both their peak conductance densities as well as the voltage-dependence of activation of Na~V~ and K~V~ channels by constraining the model AP to the experimentally recorded AP of the same neuron, with the aim to match the AP both in the *V-t* as well as the phase-plane dimensions recorded and simulated at 100 kHz ([Figure 7c](#fig7){ref-type="fig"}). To further constrain $\overset{-}{g}$~Na~ we compared the AP-evoked \[Na^+^\] with the experimental recordings using the ratiometric indicator SBFI, yielding a Δ\[Na^+^\]~i~ of on average \~1.5 ± 0.2 mM (*n* = 5, imaged at 0.5 kHz; [Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}). Ca~V~ channels were incorporated based on previously published models ([@bib61]) and Ca~V~ channel conductance was separated in high- and low-voltage (T-type) activated channels and was varied between 2 and 4 pS µm^--2^ in the AIS, 8 and 4 pS µm^--2^ in the soma and ranged between 0.5 and 4 pS µm^--2^ in the dendrites.

Statistics and data availability {#s4-16}
--------------------------------

All statistical tests were done in GraphPad Prism 8 (version 8.1.2, GraphPad Software, Inc). Sample sizes for the pharmacological experiments were estimated based on the following assumptions: to observe a 50% block (based on [@bib11]) with 25% standard deviation (relative to mean) with a power of 0.8 and a type I error probability of 0.05, we would need a minimum of 4 paired recordings per treatment (PS Software version 3.1.6).

The cutoff significance level (*P*) was 0.05. Control peak ΔF/F values at the AIS in response to both subthreshold and AP signals were tested for normality. Since both data sets passed the D'Agostino and Pearson normality test, parametric tests were used to test all differences between peak OGB-1 ΔF/F. To compare the spatial differences in signal amplitude we used one-way ANOVAs with multiple comparisons with Tukey correction for false positives. A linear regression was used to assess the synaptopodin and AIS marker length (Ankyrin G or ß4-spectrin) relationship. We used one-tailed ratio (compared log differences in the data set) paired *t*-test when analyzing all our toxin data. Differences between toxin and control give a measure of absolute reduction; differences between logarithms give a measure of relative reduction log toxin -- log control = log (toxin/control). One tailed test was used on the premise that toxins reduce Ca^2+^ signals. The exception was the effect of NCX for which we used a two-tailed ratio paired t-test. The OGB-5N peaks in response to subthreshold depolarizations passed the D'Agostino and Pearson normality test and to compare the effects of TTX and QX-314 on subthreshold Ca^2+^ responses we used two-way-ANOVA with Sidak's correction for false positives. The following data sets passed the Shapiro-Wilk test for normality, so we compared the means using parametric tests: rise and decay times of OGB1 before and after Ca^2+^ store release block, peak ΔF/F JPW3028, peak ΔF/F OGB-5N and slopes of *I*~Na~, *I*~Ca_opt~ and *I*~Ca,~ the ratio of subthreshold peak to AP peak between sodium (SBFI) and calcium (OGB-5N) fluorescence. The following data did not pass the Shapiro-Wilk test for normality, so we compared the means using nonparametric tests: the slope AP peak between sodium (SBFI) and calcium (OGB-5N) fluorescence, the peak *I*~Na~ and peak OGB-1 ΔF/F in HEK-293 cells. All data generated or analyzed are in the manuscript or supporting files. The source data files are provided for [Figures 1](#fig1){ref-type="fig"}--[7](#fig7){ref-type="fig"} and [Table 1](#table1){ref-type="table"}. The NEURON model morphology is available at NeuroMorpho.Org ID: NMO_75667, Neuron Name 2014-04-01_1 and the mod file used to model Ca^2+^ diffusion and buffering is available at ModelDB, accession 125745 (<https://senselab.med.yale.edu/ModelDB/>), with adjustments described in 'Model simulations with a multicompartmental model'.
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**Acceptance summary:**

The source of calcium entry at sites of action-potential initiation has been incompletely understood. In this study, quantitative electrophysiological, imaging, and computational approaches are used to demonstrate that voltage-gated sodium channels have a minor permeability to calcium that mediates a significant portion of depolarization-dependent calcium influx. This novel finding provides a comprehensive explanation of axonal calcium entry in mammalian cells.

**Decision letter after peer review:**

Thank you for submitting your article \"Ca^2+^ entry through Na~V~ channels generates submillisecond axonal Ca^2+^ signaling\" for consideration by *eLife*. Your article has been reviewed by four peer reviewers, including Merritt Maduke as the Reviewing Editor and Reviewer \#1, and the evaluation has been overseen by Richard Aldrich as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Bernardo L Sabatini (Reviewer \#3); James S Trimmer (Reviewer \#4).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This comprehensive study seeks to show that a source of calcium at the axon initial segment is permeation of Ca^2+^ through voltage gated Na channels. The quality and variety of quantitative electrophysiological, imaging and computational approaches that are brought to this problem is impressive. The question has been addressed previously in pyramidal cells and other neurons, and a general previous conclusion is that various calcium selective channels, Ca~V~s, are at play. However, in previous investigations, inhibition of Ca~V~s was only able to partially block influx, indicating an incomplete understanding. Here, the authors add to the story by concluding that the small calcium permeability of voltage-gated sodium channels (Na~V~s) to Ca mediates a significant portion of depolarization-dependent Ca influx in mammalian cells. This novel finding will be of wide interest. However, some key control experiments are essential to support the conclusions. In addition, a reframing of the Introduction and Discussion is essential to clarify the contribution of this report. The results are organized well and do a good job building the story. With the requested controls together with a reframed Introduction and Discussion, this paper should be a very enjoyable read.

Essential revisions:

1\) A major concern deals with the use of Ca~V~ blockers in Figure 3. There are no positive controls for any of the 7 compounds. Yet the reader needs to take this array of negative results as major support for the work\'s conclusions. For the peptides, SNX, conotoxin, there is no indication that the drugs were applied using solutions in which protein binding was pre-inhibited with BSA or cytochrome C. While at \~1 μm it likely won\'t matter much; however, it is a standard step. With puffing of the drug, the final concentration would be expected to be \~10% of the pipette concentration, again calling up the need for a positive control.

Figure 3 also shows that there are small reductions with TTA, Ni, Isradepine, Nimodipine. If you add those up, and take into account the point above, then perhaps a significant amount of the Ca enters through Ca~V~s, and thus the relative contribute of Na~V~s and Ca~V~s remains uncertain. Perhaps combinations of blockers could give a more accurate picture.

2\) Figure 5 is a fascinating and creative experiment that potentially provides a potent argument for the Na~V~ source of Ca. However, there remain concerns of whether the voltage signals before and after the TTX+voltage increase manipulation are really reflective of equivalent membrane potentials. How linear is the JPW signal? And how stable? How does the signal linearity change when the there is a large overshoot? If the transients are not an accurate reflection of the relative magnitude of AIS voltage change then the experiment is less compelling. Since the author are masters of bleb recording, why not use this to get a more direct *V*~m~ assessment than V imaging?

3\) Electrophysiological analysis. The authors should analyze AP properties recorded in current-clamp data. The APs half-width and after-depolarization should be characterized. Each independent pharmacological manipulation should be compared to the control condition and the EGTA condition, which should provide constraints on the effect of calcium influx on the AP waveform. Of particular interest is whether calcium influx through voltage-gated calcium or sodium channels has particular importance for calcium-activated potassium channels, which may be linked through nanodomain signaling. An example of this effect might be seen in the *V*~m~ traces of Figure 3A and C (the Aps look quite different with T-type block), but it is not discussed. Furthermore, slight differences in AP waveform can have profound effects on calcium influx through voltage-gated calcium channels. These effects should be ruled out when relevant. This analysis should be accompanied by discussion of Na~V~-mediated calcium influx\'s function in the AIS. For example, if the small calcium signal produced by T-Type channels is primarily responsible for shaping the afterdepolarization, then the authors should speculate on the function of the Na~V~-mediated calcium signal.

The results of these analyses are relevant for an overstated claim in the first paragraph of the Discussion. The authors write \"\[sodium channels\] generate local and rapid Ca-dependent biochemical signaling\". No experiment or analysis was done to directly evaluate this claim. Ca-dependent biochemical signaling is not addressed at all. This could be tested by examining the opening of Ca-activated K channels by Na~V~-dependent Ca influx. The \"local\" part may also be problematic. If local means \"in the same subcellular domain as the open Ca-permeable channel\" then this is trivially true. If it means something about nanodomain signaling, this has not been examined (but might potential be with analysis of Ca-activated K channels).

4\) It would also be of interest to know if Na~V~-mediated calcium influx impacts cellular firing patterns, such as spike accommodation. It is not clear from the manuscript whether this analysis could be performed without additional experimentation -- if so, it is certainly worth analyzing the data in hand to discover such potential effects.

5\) Ca release is blocked by applying 200 μm ryanodine and 5 mg/ml heparin to the intracellular solution, resulting in a nearly 50% reduction of the Ca signal. This is \~ 20 times more ryanodine than is usually bath applied to block store release. How is this concentration justified and could it possibly have any off-target effects at that dose?

6\) What efforts were made to confirm that Ca signals are not saturating? This would impact kinetics or additive effects greatly.

7\) Writing. The authors attempt to make two claims that are misleading and unnecessary for the impact of the manuscript. First, they claim that Na~V~-mediated calcium signals are a novel finding. They do this in the Abstract and in the first paragraph of the Discussion. However, they cite the multiple papers that have reported this phenomenon in squid axons. I suggest that the authors couch the novelty of their result in this literature, and instead claim that this source is novel in mammalian cells, as is done in the third paragraph of the Discussion. This would clarify the contribution of this report and deflect any unnecessary criticism about the accuracy of its claims.

Next, they write, \"the source of Ca transients at the axon initial segment and nodes of Ranvier.... is less understood\". I find that this does not accurately represent the state of the literature. There is significant knowledge related to calcium signaling in axons, including their effect on AP waveform via their interaction with calcium-activated potassium channels and the role of calcium channels in generating cell-type specific firing patterns. Accompanying these effects are multiple papers that use pharmacological compounds to identify the source of the calcium influx, all of which have failed to completely block axonal calcium signals. This point is key to the novelty and impact of Popovic et al.\'s manuscript. Instead of arguing ambiguously that axonal calcium signaling is poorly understood, we recommend that Popovic et al. explicitly discuss how the inability to completely block axonal calcium signals, together with the historical observation of a TTX-sensitive calcium current, demand a revision of our current model for mammalian axonal calcium signaling. This framework would be more accurate, informative, and erudite. This consideration should be propagated throughout the entire manuscript.

8\) In the spirit of rigor and transparency contributing to reproducibility, the authors need to provide more detail on toxin and blockers used. This should include both the source and the source and catalog numbers, similar to what they included for amplifiers, objectives, etc. Attempts to reproduce and/or extend this work rely of using the correct reagents and there is little to no detail on exactly what was used. This also holds for the antibodies used for the immunolabeling. The authors state they used these antibodies: Synaptopodin (rabbit; 1:500; Sigma-Aldrich Chemie); Ankyrin G (mouse; 1:100; Neuromab) and ßIV-spectrin (mouse; 1:250; Neuromab). However, from their websites, Sigma sells six different rabbit anti-synaptopodin antibodies, and NeuroMab distributes four different anti-Ankyrin G antibodies, and two different anti- ßIV-spectrin antibodies, all six in two different forms (pure and tissue culture supernatant). In looking at the website info the different antibodies against these targets have very different characteristics, supporting the importance of defining which specific ones were used. We suggest the authors include catalog numbers and RRID numbers for unambiguous identification of the reagents used. *eLife* suggests/requires a key resources table to promote rigor and transparency. This would be an effective way to include these details.

10.7554/eLife.54566.sa2

Author response

> Essential revisions:
>
> 1\) A major concern deals with the use of Ca~V~ blockers in Figure 3. There are no positive controls for any of the 7 compounds. Yet the reader needs to take this array of negative results as major support for the work\'s conclusions. For the peptides, SNX, conotoxin, there is no indication that the drugs were applied using solutions in which protein binding was pre-inhibited with BSA or cytochrome C. While at \~1 μm it likely won\'t matter much; however, it is a standard step. With puffing of the drug, the final concentration would be expected to be \~10% of the pipette concentration, again calling up the need for a positive control.

We have now performed new experiments to examine the efficacy of drug application. More specifically, we repeated the ω-conotoxin MVIIC (a N-, P-/Q-type Ca~V~ channel blocker) puffing experiment with addition of 0.1% BSA in the ASCF, to reduce nonspecific binding of the drug. The effect of the drug was not altered; ω-conotoxin MVIIC led to a non-significant trend to reduce the AP-evoked Ca^2+^ influx in the AIS by \~7% (*n* = 5, see Results and Figure 3B). In contrast, as a positive control experiment we imaged the Ca^2+^ in collateral boutons from the same axons, where the pressure application of the toxin from the same pipette reduced the AP-induced Ca^2+^ influx by \~90% (see Results, *P* = 0.021, *n* = 3; Figure 3B).

> Figure 3 also shows that there are small reductions with TTA, Ni, Isradepine, Nimodipine. If you add those up, and take into account the point above, then perhaps a significant amount of the Ca enters through Ca~V~s, and thus the relative contribute of Na~V~s and Ca~V~s remains uncertain. Perhaps combinations of blockers could give a more accurate picture.

The channels that significantly contributed to AP-evoked Ca^2+^ influx were T- and L-type Ca~V~ channels. To address whether their block is additive and thereby accounts for a larger fraction of the Ca^2+^ influx we performed new experiments combining the T- and L-type blockers TTA-P2 and isradipine, respectively. We did not combine all four blockers, since they have shared targets and combining blockers with the same targets is in essence similar to increasing the blocker concentration, which may lead to off-target effects. TTA-P2 and isradipine were selected since they individually showed the most robust effect (least variance). The observed block was a 27.2% reduction in the AP-evoked peak in ∆F/F (relative to control, *P* = 0.0071, *n* = 5; Figure 3B). This block was less in comparison to the linear sum of block 33.6% (TTA-P2, 18.7% + Isradipine, 14.9%) and further underscores the idea that voltage-gated Ca^2+^ channels at the AIS are not the only source for Ca^2+^ influx.

> 2\) Figure 5 is a fascinating and creative experiment that potentially provides a potent argument for the Na~V~ source of Ca. However, there remain concerns of whether the voltage signals before and after the TTX+voltage increase manipulation are really reflective of equivalent membrane potentials. How linear is the JPW signal? And how stable? How does the signal linearity change when the there is a large overshoot? If the transients are not an accurate reflection of the relative magnitude of AIS voltage change then the experiment is less compelling. Since the author are masters of bleb recording, why not use this to get a more direct V~m~ assessment than V imaging?

We are pleased to read the reviewers appreciated the experimental design. Regarding the possibility to record in whole-cell patch-clamp configuration from axon blebs; this approach has its advantages and disadvantages. While it has excellent signal-to-noise for voltage recordings, in transected axon blebs intracellular Ca^2+^ is increased and plays a role in the cytoskeletal organization for resealing and regrowth (Bradke et al. Nat Rev Neurosci 13, 2012). Since the focus of the present study is the dynamics of intracellular Ca^2+^ under physiological conditions we decided that electrical recording (or imaging) from blebs will have confounding effects.

Using a high-speed imaging experiments strategy, we can record from unperturbed axons. The synthetic dye JPW has a very fast activation time constant (\~11 µs) and is linear over a large voltage range (--125 to 125 mV, Ehrenberg et al., Biophys J 51, 1987) making it the voltage-sensitive dye of choice to track fast action potentials in neurons and in particular in axons (Cohen et al. Cell 180, 2020; Popovic et al. The Journal of Physiology 589, 2011). The reviewers raised two concerns regarding voltage imaging in this experiment: the stability and the linearity of the voltage dye. To address the first concern, we measured the baseline fluorescence of all recordings shown in Figure 5 and did not observe a change in baseline fluorescence between conditions (data not shown, *P* = 0.452, ordinary one-way ANOVA, *n* = 9), confirming that the dye is stable over the time period in which the experiments were performed. To address the linearity of the dye: we agree that linearity had not been examined over the larger voltage range as was used here (from resting membrane potential to +170 mV). In the revised manuscript we addressed this in HEK293 cells, in which a reliable and stable voltage-clamp can be maintained. We performed experiments in which JPW3028 fluorescence was imaged while clamping the cell across the range of potentials used in the AP-clamp experiment in Figure 5. The results show that the relationship between JPW ∆F/F and membrane potential is linear between --75 up to +175 mV, with Pearson's correlation coefficient r \> 0.99 in all cells recorded (see Figure 5---figure supplement 1).

> 3\) Electrophysiological analysis. The authors should analyze AP properties recorded in current-clamp data. The APs half-width and after-depolarization should be characterized. Each independent pharmacological manipulation should be compared to the control condition and the EGTA condition, which should provide constraints on the effect of calcium influx on the AP waveform. Of particular interest is whether calcium influx through voltage-gated calcium or sodium channels has particular importance for calcium-activated potassium channels, which may be linked through nanodomain signaling. An example of this effect might be seen in the V~m~ traces of Figure 3A and C (the Aps look quite different with T-type block), but it is not discussed. Furthermore, slight differences in AP waveform can have profound effects on calcium influx through voltage-gated calcium channels. These effects should be ruled out when relevant. This analysis should be accompanied by discussion of Na~V~-mediated calcium influx\'s function in the AIS. For example, if the small calcium signal produced by T-Type channels is primarily responsible for shaping the afterdepolarization, then the authors should speculate on the function of the Na~V~-mediated calcium signal.

We agree with the reviewers the AP changes may be informative and add to our understanding of the function of Na~V~ mediated Ca^2+^ influx. In the revised version we now show the analysis of individual APs recorded from the soma in Figure 9 and Table 1. Two conditions with the largest effect on Ca^2+^ influx were compared: the combined block of T- and L-type Ca~V~ channels and preventing all Ca^2+^ influx by lowering extracellular Ca^2+^ concentration by bath application of EGTA (Figure 3). Blocking T- and L-type Ca^2+^ channels reduced the afterdepolarization while leaving the AP half-width unaffected (ADP, mean difference = --2.9 mV, *P* = 0.042, FWHM, mean difference = 0.05 ms, *P* = 0.17, *n* = 5). In contrast, lowering extracellular Ca^2+^ by EGTA increased the AP half-width and afterhyperpolarization (AP half-width, mean difference = 0.29 ms, *P* = 0.018, AHP, mean difference = +19.1 mV *P* = 0.048, *n* = 4). These data suggest that the Ca^2+^ sources affect somatic AP shape differentially: the T- and L-type channels play a role in the delayed afterdepolarization while in the EGTA condition, also the submillisecond-rapid Na~V~-mediated Ca^2+^ entry is abolished, which potentially provides a route to activate BK channels and shorten the AP half-width. While we have not directly examined BK~Ca~ channels, these data are consistent with the work of Bock and Stuart, 2016, and Yu et al., 2010, showing that Iberiotoxin (IbTx)-mediated block of BK~Ca~ channels increases the AP width duration at the soma of L5 neurons and AIS. Interestingly, local IbTx application at the first node of Ranvier also increases the half-width duration where Ca^2+^ uncaging shortens the half-width (Roshchin et al., 2018). We have now included these ideas in the Discussion.

> The results of these analyses are relevant for an overstated claim in the first paragraph of the Discussion. The authors write \"\[sodium channels\] generate local and rapid Ca-dependent biochemical signaling\". No experiment or analysis was done to directly evaluate this claim. Ca-dependent biochemical signaling is not addressed at all. This could be tested by examining the opening of Ca-activated K channels by Na~V~-dependent Ca influx. The \"local\" part may also be problematic. If local means \"in the same subcellular domain as the open Ca-permeable channel\" then this is trivially true. If it means something about nanodomain signaling, this has not been examined (but might potential be with analysis of Ca-activated K channels).

With local we were referring to the fact that the AIS and nodes show hot spots for Ca^2+^ influx (Figure 1). However, we agree with the reviewers we do not have evidence for biochemical signaling and removed such claims from the manuscript. Our data indicate that AP width is Ca^2+^ dependent but T- and L-type Ca^2+^ channel independent, leaving open the possibility that rapid Na~V~-channel mediated Ca^2+^ influx is a trigger for BK channel opening (Figure 9 and Table 1). These findings are well in agreement with the work of Roshchin et al., 2018, showing that AIS and node of Ranvier Ca^2+^ activates BK channel-mediated repolarization of the AP in the L5 pyramidal neuron. Nevertheless, to provide direct evidence that it is the Na~V~-mediated Ca^2+^ entry that activates BK channels would require knocking down the molecular mechanism mediating the transfer of Ca^2+^ through the pore, performing direct voltage-clamp of BK currents, etc. Such additional experiments go beyond the aim of the present study to identify the sources of axonal Ca^2+^ entry.

> 4\) It would also be of interest to know if Na~V~-mediated calcium influx impacts cellular firing patterns, such as spike accommodation. It is not clear from the manuscript whether this analysis could be performed without additional experimentation -- if so, it is certainly worth analyzing the data in hand to discover such potential effects.

This point has been answered in more detail above in point \#3.

> 5\) Ca release is blocked by applying 200 μm ryanodine and 5 mg/ml heparin to the intracellular solution, resulting in a nearly 50% reduction of the Ca signal. This is \~ 20 times more ryanodine than is usually bath applied to block store release. How is this concentration justified and could it possibly have any off-target effects at that dose?

The ryanodine concentration we used is indeed 20 times higher compared to the reported low affinity *K*~d~ of RyRs (10 µM, Sutko et al. Pharmacol Rev. 49, 1997). This is a similar concentration as applied previously in combination with high speed imaging (Jaafari, De Waard and Canepari, 2014). These authors found no impact on peak ∆F/F evoked by single AP-induced Ca^2+^ in dendrites with blockers before and after intracellular application of ryanodine receptor block. If off-target effects are present they are thus not detectable in dendrites. That we find a change in the AIS is consistent with the large ER organelle in these pyramidal neurons (Figure 2).

> 6\) What efforts were made to confirm that Ca signals are not saturating? This would impact kinetics or additive effects greatly.

In some of our imaging experiments we also recorded the fluorescence in response to multiple APs for both OGB-1 and OGB-5N. We observed, however, that the peak ∆F/F in response to a single AP is well below dye saturation (OGB-1, 25 ± 2.7 %, *n* = 8 and OGB-5N, saturation not observed with 3 spikes, *n* = 3). We are therefore confident that the Ca^2+^ fluorescence we quantified in this paper (subthreshold stimuli and a single AP) are in the ∆F/F range from dye saturation.

> 7\) Writing. The authors attempt to make two claims that are misleading and unnecessary for the impact of the manuscript. First, they claim that Na~V~-mediated calcium signals are a novel finding. They do this in the Abstract and in the first paragraph of the Discussion. However, they cite the multiple papers that have reported this phenomenon in squid axons. I suggest that the authors couch the novelty of their result in this literature, and instead claim that this source is novel in mammalian cells, as is done in the third paragraph of the Discussion. This would clarify the contribution of this report and deflect any unnecessary criticism about the accuracy of its claims.

We have now revised these statements, removed primary claims and thoroughly rewrote the Abstract, Introduction and parts of the Discussion. The first line in the Discussion now reads "We identified Ca^2+^ permeation through Na~V~ channels as a source for activity-dependent Ca^2+^ entry in mammalian axons".

> Next, they write, \"the source of Ca transients at the axon initial segment and nodes of Ranvier.... is less understood\". I find that this does not accurately represent the state of the literature. There is significant knowledge related to calcium signaling in axons, including their effect on AP waveform via their interaction with calcium-activated potassium channels and the role of calcium channels in generating cell-type specific firing patterns. Accompanying these effects are multiple papers that use pharmacological compounds to identify the source of the calcium influx, all of which have failed to completely block axonal calcium signals. This point is key to the novelty and impact of Popovic et al.\'s manuscript. Instead of arguing ambiguously that axonal calcium signaling is poorly understood, we recommend that Popovic et al. explicitly discuss how the inability to completely block axonal calcium signals, together with the historical observation of a TTX-sensitive calcium current, demand a revision of our current model for mammalian axonal calcium signaling. This framework would be more accurate, informative, and erudite. This consideration should be propagated throughout the entire manuscript.

We thank the reviewer for the suggestion about positioning the research findings. As indicated above, we have followed the suggestions and revised the manuscript. More specifically, we toned down novelty claims and now more clearly indicate how Ca^2+^ influx through Na~V~ channels confirms and extends previous studies reporting TTX-dependent and Ca~V~ -dependent Ca^2+^ influx in axons.

> 8\) In the spirit of rigor and transparency contributing to reproducibility, the authors need to provide more detail on toxin and blockers used. This should include both the source and the source and catalog numbers, similar to what they included for amplifiers, objectives, etc. Attempts to reproduce and/or extend this work rely of using the correct reagents and there is little to no detail on exactly what was used. This also holds for the antibodies used for the immunolabeling. The authors state they used these antibodies: Synaptopodin (rabbit; 1:500; Σ-Aldrich Chemie); Ankyrin G (mouse; 1:100; Neuromab) and ßIV-spectrin (mouse; 1:250; Neuromab). However, from their websites, Σ sells six different rabbit anti-synaptopodin antibodies, and NeuroMab distributes four different anti-Ankyrin G antibodies, and two different anti- ßIV-spectrin antibodies, all six in two different forms (pure and tissue culture supernatant). In looking at the website info the different antibodies against these targets have very different characteristics, supporting the importance of defining which specific ones were used. We suggest the authors include catalog numbers and RRID numbers for unambiguous identification of the reagents used. eLife suggests/requires a key resources table to promote rigor and transparency. This would be an effective way to include these details.

We have included a completed Key Resources table in the Materials and methods section.
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